Wantstats
IndustriesCompaniesCharts & Stats
Leads DBAdvisoryPricingContact us
Login
/Company Profiles

Deep Intelligence Across Industries

All CompaniesFortune 500Aerospace & Defense iconAerospace & DefenseAgricultureAutomotive iconAutomotiveFinancial Services iconFinancial ServicesChemicals & Materials iconChemicals & MaterialsConsumer Goods iconConsumer GoodsEnergy & Power iconEnergy & PowerEquipment & Machinery iconEquipment & MachineryFood & Beverages iconFood & BeveragesHealthcare & Pharma iconHealthcare & PharmaInformation Technology iconInformation TechnologyManufacturing & ConstructionMRO iconMROProfessional Services iconProfessional ServicesSemiconductors

Showing 14441 companies

Daechang

Daechang Forging Co., Ltd.

Premium
Information Technology

Daechang Forging is a Gimhae-based mid-sized manufacturer of forged undercarriage components for crawler-type construction machinery, principally track shoe assemblies, track link (chain) assemblies, rollers, idlers, segments and sprockets used on excavators and dozers, with a smaller legacy line of automotive crankshafts. It sells to global construction-equipment OEMs for first fit and to aftermarket channels, and owns a US aftermarket distributor (Trek Inc.), giving it direct access to North American replacement demand. The parent exported roughly two-thirds of its sales in 2021–2023 and reports trading with about 80 customers in about 30 countries. Production is asset-light relative to peers: by the company's own description, about 40% of process steps are in-house and 60% outsourced to local partners. The company has a net cash balance sheet, a 48% family-controlled shareholder register, and has added overseas capacity through a 66.67%-owned plant in Chennai, India and a 50% joint venture in Anhui, China. --- **Company's own description (paraphrased from the Q1 2026 quarterly report summary).** Daechang Forging machines and assembles crawler-track components for heavy-equipment undercarriages — links, rollers and shoes — and delivers them as OEM and after-sales (A/S) parts to excavator and bulldozer manufacturers. It also supplies crankshafts, a core automotive engine component, for passenger and commercial vehicles. The consolidated group comprises three subsidiaries: Trek Inc. (USA), Track Design India Private Limited (India) and Bongnim Metal Co., Ltd. (Korea) (Investing.com Korea, 14 May 2026, summarising the DART quarterly report). **Independent characterisation.** Functionally, Daechang is a Tier-1 component supplier to the global crawler-equipment industry and a branded aftermarket participant in North America. Its economic engine is the track shoe and track link assembly business, which together accounted for about 80% of parent sales in 2023 (KRW 157.2 bn shoe assemblies plus KRW 64.1 bn link assemblies out of KRW 277.0 bn; IR deck Aug 2024). Its value proposition rests on forging know-how, assembly of complete track groups, and cost competitiveness achieved partly through a regional outsourcing network in the Gimhae/Gyeongnam forging cluster. **Revenue model.** 100% product sales; no service, subscription or licensing revenue is disclosed. Within the parent, sales split between OEM first-fit supply and A/S (aftermarket): Source: company IR deck, 26 Aug 2024 (chart labelled "OEM / AS"). The same chart shows FY2024 at KRW 175.0 bn OEM and KRW 80.0 bn A/S; these were presented in August 2024 before year-end and do not reconcile to the reported FY2024 parent revenue of KRW 230.6 bn, so they are treated as management projections, not actuals. **Value-chain position.** Raw steel → cutting → heating → forging → machining → shot blasting → assembly → painting → shipment. The company states that about 40% of these process steps are performed in-house and about 60% are outsourced (IR decks 2023 and 2024). Daechang therefore sits between steel suppliers/forging sub-contractors upstream and equipment OEMs and parts distributors downstream. **Customer types.** (1) Global construction-equipment OEMs (first fit); (2) aftermarket dealers and distributors; (3) its own US distribution subsidiary Trek Inc.; (4) automotive customers for crankshafts (small share). **End-markets.** Construction (excavators, dozers), mining (via large excavators), and to a minor extent automotive (passenger and commercial vehicle engines). Construction and mining demand drive the business. **Customer concentration.** The company states that its top eight customers account for more than 80% of parent sales. Customer names are masked in IR materials. Source: IR deck 26 Aug 2024. H1 2024 values: VO 23.3, HY 10.9, DO 17.9, TR 15.1, TA 6.7, SH 9.5, SF 9.4, JC 12.6, others 15.6, total 121.0 (KRW bn). The company does not identify the masked names; the largest account (VO) and the 2022 Volvo quality award are consistent with Volvo being a major customer, and TR is consistent with the subsidiary Trek Inc., but neither identification is confirmed by the company. In 2023 the eight named accounts represented 84.8% of parent sales (derived).

Revenue$0.2B
Employees85
Market CapN/A
Founded1955
Gimhae, South Korea

Unlock Verified Contacts

Access verified employee contacts

Decision-maker information to support your sales, lead generation, and business development. 5 users, 5,500 credits a month with rollover, and one credit per contact email.

USD650/mo
Buy Now

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
MR
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
BL
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
MI
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
RK
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
JL
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
AM
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Wantstats logo

Move faster. Think smarter. Win bigger.

Join our data driven community.

© 2026 All rights reserved by Wantstats Research and Media Pvt Ltd

footer vector

Pages

  • About
  • News
  • Charts & Stats
  • Contact
  • Ecosystem pricing
  • Privacy policy

Address

Wantstats Research and media Pvt. Ltd, Office No 104, Pentagon 4,
Magarpatta City, Pune - 411028,
Maharashtra, India.

Contact

support@wantstats.com

Follow Us

Follow Wantstats on FacebookFollow Wantstats on InstagramFollow Wantstats on LinkedInFollow Wantstats on YouTubeFollow Wantstats on WhatsApp
Daechang

Daechang Co., Ltd.

Premium
Information Technology

**Disambiguation:** Daechang Co., Ltd. is not related to the following separately listed companies that share the "Daechang" name: - Daechang Forging (대창단조), a construction-machinery undercarriage maker in Busan/Gimhae. - Daechang Steel (대창스틸, KOSDAQ 140520). - Daechang Solution (대창솔루션, KOSDAQ 096350), a cast-steel marine engine parts maker. Daechang is South Korea's largest producer of brass rod and the operating core of the family-controlled Daechang Group. The group's holding company, Seowon Co., Ltd., owns about 40% of Daechang. Daechang makes extruded and drawn brass rods, hollow bars, wire, ingots, copper-alloy rods and billets, mainly from recycled brass scrap. Customers are second-tier fabricators that machine or forge the material into valves, plumbing fittings, fasteners, electrical and electronic connectors, automotive and machinery components, and semiconductor-related parts. Industry profiles credit the company with a 44–46% share of the domestic brass rod market and about 144,000 tonnes of annual rod capacity. The company describes itself as Asia's largest brass rod exporter, shipping to about 20 countries. Consolidated revenue reached KRW 1.47 trillion in FY2025. Margins are thin (3.5% operating margin in FY2025) and earnings move closely with LME copper prices, metal-hedging results and inventory valuation. Leverage is high and largely short-term. U.S. anti-dumping and countervailing duty orders on Korean brass rod have applied since June 2024. --- ### What the company does Daechang is a first-stage non-ferrous processor. It buys copper, zinc and, above all, brass scrap. It melts and alloys the metal, casts billets, extrudes them into rods, hollow bars and coils, and finishes them by drawing, straightening and cutting. Products are sold to second-stage processors. These include automotive parts vendors, valve and plumbing fitting makers, fastener makers, electrical and electronic component makers, and machine shops. A 2021 eBest Investment & Securities report described the model this way: copper and zinc are refined into primary brass products and supplied to secondary processors. The main downstream channels in that report were automotive vendors, building plumbing and valves, and electronic components. The KIRS/NICE technology analysis report (Nov 2025) states several further points: - Daechang performs the entire copper-based brass rod process in-house. - Its portfolio includes brass rod, tough-pitch copper and copper-alloy aquaculture netting. - It sells through seven domestic and overseas subsidiaries. - It exports brass rod to about 20 countries. - Its main raw material is brass scrap generated by manufacturing industries, which the report frames as resource recycling. ### Company's own description Daechang's English-language profile, as reproduced by financial databases, says it produces and sells brass-related products in Korea under the BRASSONE brand. It says the products serve as materials for parts used in semiconductors, electrical and electronic equipment, cars, ships and machinery. The profile also notes that the company was renamed from Daechang Industrial Co., Ltd. in 2010 and is headquartered in Siheung. ### Revenue model **Product sales: effectively 100% of revenue:** There is no subscription, licensing or service revenue of significance. **Pricing is a metal pass-through plus a fabrication premium:** In 2021, eBest reported that product prices were set off a 45-day average of LME copper. Revenue therefore rises and falls with copper prices even when volumes are flat. **Margin drivers:** - the fabrication premium over metal cost; - the scrap-versus-primary metal spread; - inventory gains or losses (Consumer Times, May 2026, reports the company holds about three months of raw material); - realised and unrealised derivative (metal and FX hedge) results, which are booked below operating profit; - capacity utilisation. **Mix (historical, consolidated):** brass rod 44%, wire bar 38%, other 18% (eBest, June 2021, based on company data). A later parent-only breakdown from secondary sources shows brass rod about 92% and merchandise/other about 8%. The difference reflects the subsidiary Taewoo (copper wire bar and billet), which is consolidated. ### Value-chain position | Stage | Participants | Daechang's role | |---|---|---| | Mining and smelting (copper, zinc) | Global miners; Korean smelters | Buys refined metal as a supplement to scrap | | Scrap collection | Scrap dealers; fabricators' swarf return | Main feedstock | | Primary non-ferrous processing (rod, bar, wire, billet) | Daechang, Seowon, Booyoung Industry, Taewoo (subsidiary) | Core activity | | Secondary processing (machining, forging) | Valve, fitting, fastener, connector, auto parts makers | Customers | | End products | Building, HVAC-R, automotive, electronics, semiconductor equipment, shipbuilding, machinery | End markets | ### Customer types and end-markets The customer base is B2B: processors, distributors and wholesalers in Korea, plus export customers in Southeast Asia, Australia, New Zealand, the United States, Europe and India, according to the Komachine company profile. End-markets named across company and industry sources are: - semiconductors; - electrical and electronics; - automotive; - shipbuilding; - industrial machinery; - valves and plumbing; - HVAC-R, through the subsidiary Essentech's refrigerant ball valves. ### Independent characterisation Daechang is a scale-driven, low-margin commodity converter. Its competitive edge comes from three things: cost and scrap-sourcing advantages, domestic market share, and logistics proximity to Korean customers. Reported earnings are volatile for reasons largely outside management's control: - copper price direction; - the timing gap between purchases and pricing; - hedge accounting effects; - interest costs on about KRW 470 bn of debt. The equity trades at about 0.3× book value. That book value is supported largely by revalued land (revaluation surplus of KRW 121 bn in FY2025). The market is therefore valuing the company as an asset-heavy, low-return business, not on its operating earnings.

Revenue$1.0B
Employees335
Market Cap$0.1B
Founded1974
Siheung, South Korea
Daebo

Daebo Magnetic Co., Ltd.

Premium
Information Technology

Daebo Magnetic is a Korean specialist in magnetic separation equipment. It has five decades of history in high-gradient magnetic technology. Its core product is the electromagnetic filter (EMF, 전자석탈철기). The EMF removes ppm-to-ppb levels of ferromagnetic contamination from lithium-ion battery cathode and anode powders and slurries, a step that bears directly on cell safety and yield. The company co-developed dry-type EMF with Samsung SDI and localised the technology in 2008. It says it was first in the world to commercialise wet-type (slurry) EMF. It supplies the major Korean cell and cathode makers and has also sold into Chinese and North American lines. Management claims about 70% global share in battery-grade EMF; independent verification is not available. A diversification into lithium-salt toll processing (2021–2025) failed and has been written down. Daebo now operates as a pure-play, highly cyclical battery capital-equipment supplier. It is loss-making, with a sharply reduced revenue base and rising balance-sheet strain. --- ### What the company does Daebo Magnetic designs and manufactures electromagnets and magnet-based separation equipment [S32]. The technology uses strong magnetic fields to capture ferrous or ferromagnetic particles as material flows through a magnetised filter matrix. The recovered contaminants are then flushed out automatically. The company's commercial franchise rests on lithium-ion battery manufacturing. In this application, metallic contamination in cathode material is a recognised cause of internal short circuits and thermal runaway [S32]. Daebo's EMF systems remove trace iron and other magnetic impurities from four types of material: - cathode active material (CAM) powders, - precursor (pCAM), - anode materials, - electrode slurries on the cell line. The company has stated that its next-generation unit targets impurity reduction down to about 15 ppb [S29]. ### Company's own description The current company website describes two divisions [S16]: **Equipment Division (장비사업부):** The website calls this the leading core business. It presents the division as developing and manufacturing advanced magnetic equipment for diverse industrial applications, built on 50 years of accumulated technology. It also claims a dominant position in the world EMF (탈철기) market, supported by its delivery record. **Materials Division (소재사업부):** The website describes this division as researching and commercialising new battery materials for EVs and portable electronics. In practice, the division provided toll processing of lithium hydroxide and lithium carbonate (crushing, drying and iron removal). Operations effectively ceased in 2025–Q1 2026 [S4]. Data aggregators drawing on the 2026 half-year report classify the current revenue mix as 100% EMF (전자석탈철기) [S2][S8]. ### Business model and revenue model | Dimension | Characterisation | |---|---| | Revenue type | Almost entirely project-based capital-equipment sales (product revenue). Toll-processing service revenue, previously reported net of the material value, was immaterial by FY2025 (KRW 0.05 bn) and nil in Q1 2026 [S4][S32]. | | Subscription / licensing | None disclosed | | Recurring element | Spare parts, filter screens and maintenance, implied by the installed base. Separate disclosure of aftermarket revenue was not found in retrieved sources. | | Revenue recognition | Recognised on completion of installation and commissioning (설치 및 시운전 완료 시점). Management cited this policy as a cause of quarter-to-quarter revenue lumpiness in Q1 2026 [S4]. | | Pricing (indicative) | Korea IR Council (KIRS) research reported that wet EMF units for cell lines sell for about KRW 100 mn each, higher than dry units [S18]. | | Order profile | Single-supply contracts disclosed when they exceed regulatory thresholds. Examples: KRW 1.9 bn with HRK (April 2021); about KRW 2.0 bn with HRK Rongbai (September 2021); about KRW 2.2 bn with HRK (DongRi) (November 2021) [S26]. | ### Value-chain position Daebo sits in Tier-2 process equipment within the battery supply chain. It supplies a filtration and purification step installed at these points: 1. **Cathode/precursor makers:** before and after calcination of precursor with lithium hydroxide or lithium carbonate [S22]. 2. **Anode material makers.** 3. **Cell manufacturers:** on electrode slurry lines, using wet EMF [S18]. 4. **Mines and lithium processors:** mentioned in Asia Economy coverage [S27]. Demand is therefore a direct function of new battery-materials and cell capacity additions (greenfield capex), with a smaller replacement and retrofit component. ### Customer types and named customers | Customer category | Named customers in public sources | Source | |---|---|---| | Korean cell makers | LG Energy Solution, Samsung SDI, SK On | [S21][S29] | | Korean cathode makers | EcoPro BM, LG Chem, L&F, POSCO Future M (formerly POSCO Chemical), Cosmo AM&T | [S21][S28][S29] | | Chinese battery / CAM makers | CATL, BYD, HRK / HRK Rongbai / HRK (DongRi) (contract counterparties as named in filings) | [S14][S26][S29] | | North America | "A large North American battery maker" supplied since 2020. Digital Daily reported that Tesla had ordered Daebo EMF. | [S17][S22] | | Non-battery | Dry EMF and separators used in food, pharmaceuticals, chemicals and ceramics. Earlier supply to municipal, resource-recovery and water-utility projects (2010). | [S24][S16] | The company website lists Korea, USA, China, Australia, Hungary, Sweden, Finland, Canada, Poland, France, Malaysia, Japan, Kazakhstan and Indonesia in its "Global Network" [S16]. ### End-markets **Primary (≈100% of H1 2026 revenue):** lithium-ion battery materials and cells for EVs and energy storage systems (ESS) [S2][S17]. **Optional/emerging:** sodium-ion battery materials (market narrative in 2025) [S30]; LFP and battery recycling (identified by KIRS as potential extensions) [S18]. **Legacy industrial:** recycling and waste sorting (non-ferrous separators, drum separators), mining, ceramics, food and chemicals [S16][S22][S24]. ### Independent characterisation Daebo Magnetic is best understood as a niche, technology-led monopoly-style supplier serving an end-market that has turned from hyper-growth to deep cyclical contraction. **Strength of the franchise.** Daebo's moat rests on three things: - magnetic-circuit know-how built over decades, - qualification status with every major Korean battery-materials producer, - first-mover status in wet EMF. **The difficulty.** The business model offers almost no counter-cyclical ballast: - Revenue depends on customers building new lines. - Revenue is recognised only on commissioning. - A diversification into lithium-salt toll processing was intended to provide recurring revenue. It failed, and the associated fixed assets have been impaired [S4][S7]. The result is a company whose revenue swung within four years from KRW 42.9 bn (FY2021) to KRW 108.6 bn (FY2022) and then to KRW 26.1 bn (FY2025) [S1]. Quarterly revenue in Q1 2026 was only KRW 1.1 bn [S3].

Revenue$0.0B
Employees51
Market CapN/A
Founded1974
Hwaseong, South Korea
DAEATI

DAEA TI Co., Ltd.

Premium
Information Technology

DAEA TI is South Korea's specialist domestic supplier of railway signalling and train-control systems. Its core is the Centralized Traffic Control (CTC) platform, which it localised. That platform runs Korea's national Railway Traffic Control Center (built 2002) and is now the basis of the ~₩250bn Second Railway Traffic Control Center (Osong) consortium project. Around this core the company has built a domestically developed portfolio: electronic interlocking, ATP/ATC/ATO, the LTE-R-based Korean Train Control System (KTCS-2) for mainline and high-speed rail, and KTCS-M (localised CBTC) for urban transit. Several of these products are certified to SIL4. Revenue is about 96–99% domestic and comes from public-sector procurement through the National Rail Network Authority (Korea National Railway), Korail, the Public Procurement Service and metro operators. The investment case rests on Korea's multi-year rail build-out and the national migration to KTCS-2 (~₩2.2 trillion through 2032), together with an order backlog of roughly three years of revenue. Against this sit structurally thin operating margins (~5%), dependence on non-operating gains, and frequent leadership turnover. --- ### What the company does DAEA TI designs, manufactures, installs, tests, commissions and maintains railway signalling, train-control and railway communication systems. Its investor materials group the business into three product families: 1. **SIG (Signalling):** CTC/ATS traffic control and supervision, train management systems (TMS, including an AI-based TMS), KTCS-2, KTCS-M, ATP/ATC/ATO, CBTC, ETCS, electronic interlocking (EIS), track circuits, balises, resignalling, signal-violation prevention and platform-screen-door supervision. 2. **I&C (Information & Communication):** LTE-R (LTE-based railway wireless communication), optical transport network (OTN) equipment, and distribution of terrestrial trunked radio (TRS/PMR). 3. **M&S (Modelling & Simulation):** rail and aviation simulators, 3D modelling, verification of wayside-equipment safety and interoperability by simulation, large display panels (LDP), and interior fit-out of railway traffic control centres. Third-party profiles (Investing.com; EMIS) describe the same scope. They state that the company plans, designs, constructs, operates, maintains and consults on railway operation control for main lines, high-speed lines, urban transit, light rail and industrial railways. ### Company's own description The FY2025 business report states the founding purpose as development and supply of railway signalling and control systems (Q1 2026 report, Section I). Its IR decks carry the tagline "Good to Great signal". They describe the company as a "Total Solution Provider" with a complete signalling line-up covering on-board, wayside and control-centre equipment plus safety/interoperability verification. The stated vision is to be a global company whose railway technology changes how people live (2021 IR deck, paraphrased). Stockplus's company summary adds that DAEA TI has localised core products across signalling, starting with CTC, and executes turnkey projects. ### Business and revenue model | Dimension | Characterisation | |---|---| | Revenue type | Project/contract revenue recognised over time. Contract assets are a large share of current assets: ₩33.3bn at FY2024 year-end versus ₩149.1bn revenue (June 2025 IR appendix). | | Product vs. service mix | Not split in disclosures. The portfolio combines proprietary hardware and software systems, installation and maintenance services, and software/simulation (M&S). | | Subscription / licensing | None disclosed | | Contracting | Mainly public tenders, often as "long-term continuing contracts" with staged follow-on contracts (e.g., Jinjeop Line depot contract disclosure, 28 Aug 2026). Some large projects are run in consortia (Second Railway Traffic Control Center). | | Cost structure | High cost of sales (FY2024 COGS 83.6% of revenue). FY2024 raw-material purchases were ₩41.7bn, 90.1% of them for SIG (The Value News, 2 Apr 2025, citing the FY2024 business report). Payroll was ₩30.4bn, 20.6% of FY2025 separate revenue (ETF Shopping). | ### Value-chain position DAEA TI is a Tier-1 systems supplier and integrator. It sits between government infrastructure owners and operators (National Rail Network Authority, Korail, Seoul Metro, Busan Transportation Corporation, the Public Procurement Service as contracting agent) and component suppliers. For turnkey signalling it often contracts directly with the owner. It also acts as a subcontractor to EPC firms (e.g., DL E&C, formerly Daelim, for GTX-A on-board signalling in 2020) and works alongside rolling-stock OEMs such as Hyundai Rotem. ### Customers and end-markets **Customers:** National Rail Network Authority (formerly Korea Rail Network Authority), Korail, the Railway Traffic Control Center, Seoul Metro, Busan Transportation Corporation, the Public Procurement Service, EPC contractors, and overseas rail agencies (Egyptian National Railways, Philippine and Indonesian projects, Mongolia). Source: company IR decks; The Value News (6 Feb 2024; 17 Dec 2025). **End-markets:** conventional mainline, high-speed rail, metropolitan express (GTX), urban metro, light rail/tram, and industrial rail. **Geography:** about 96% domestic in FY2024 (overseas ≈ ₩5.9bn) and 99% domestic in Q2 2026 (Butler). ### Independent characterisation DAEA TI is a mid-sized, founder-controlled engineering company. Its competitive position is unusually strong in one domain, centralised traffic control for Korea's national network, and it holds credible positions in interlocking and the government-led KTCS programmes. Economically it behaves like a public-works contractor. Revenue is lumpy and depends on the tender cycle, gross margins are mid-to-high teens, and working capital ties up cash in receivables and contract assets. Reported net income has recently exceeded operating income. In FY2025, net income of ₩20.4bn was about 2.7 times operating income of ₩7.6bn, helped by gains on investment property and financial instruments (Electimes, 20 Mar 2026). Since 2024–2025 management has diversified into venture capital (Daea Investment) and a small Greek-yogurt F&B business. These moves are strategically unrelated to signalling and complicate the equity story.

Revenue$0.1B
Employees510
Market CapN/A
Founded1995
Bucheon, South Korea
DAE

DAE YOUNG Packaging.Co., Ltd.

Premium
Information Technology

| Field | Detail | |---|---| | Legal name (Korean) | 대영포장 주식회사 (abbreviated 대영포장㈜) | | Legal name (English, as used in filings) | DAE YOUNG Packaging.Co., Ltd. (also rendered DAEYOUNG PACKAGING CO.,LTD) | | Former names | None identified | | Founded / incorporated | 1 June 1979 (DART quarterly report 2021; Jobkorea company data) | | Incorporation jurisdiction | Republic of Korea | | Headquarters | 265 Sandan-ro (Wonsi-dong), Danwon-gu, Ansan-si, Gyeonggi-do 15429, Korea (Banwol Industrial Complex) | | Listing | KOSPI (Korea Exchange), listed 6 March 1990 | | Ticker | 014160 (Reuters/Yahoo style 014160.KS; some vendors A014160) | | ISIN | KR7014160001 (derived from KRX standard ISIN format) | | CUSIP | Not applicable (no US listing) | | Group affiliation | Daeyang Group (대양그룹); subsidiary of Shindaeyang Paper Co., Ltd. (KOSPI: 016590) | | Controlling shareholder | Shindaeyang Paper 50.79% direct; 56.26% with related parties (filings of 24 Aug, 30 Sep and 8 Oct 2026) | | Fiscal year end | 31 December | | Representative directors | Kang Byung-eun (강병은) and Son Yong-soo (손용수), co-CEOs | | Employees | 334 at end-2025 (297 permanent, 37 contract); 317 at 30 June 2026 (Jobkorea) | | Employee trend | 359 (2021), 340 (2022), 316 (2023), 345 (2024), 334 (2025) | | Auditor | — | | Paid-in capital | KRW 54.2bn (end-2025) | | Shares outstanding | 21,678,909 after the 5:1 consolidation (108,394,549 before) | | Treasury shares | 4.88% of issued shares (Butler) | | Share price | KRW 2,800 (close, 19 Oct 2026, post-consolidation; Valueline) | | Market capitalisation | KRW 60.7bn (19 Oct 2026; Valueline/Butler) | | Listing status | Administrative issue (관리종목) since 12–13 Aug 2026 for price below KRW 1,000; cure period running | | Websites | www.dygroup.co.kr (group site, listed in brief); www.dypc.co.kr also cited by data vendors | Its legal name, ticker and website have not changed in substance. The company has, however, undergone a capital-structure change (5:1 share consolidation, effective 19 September 2026) and is currently designated an "administrative issue" (관리종목) on the KOSPI market for a sub-KRW 1,000 share price. Both are material to any reader using legacy price data. | Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |---|---|---|---|---|---| | Employees (headcount) | 359 | 340 | 316 | 345 | 334 | | Average salary (KRW M) | 57.51 | 57.45 | 67.52 | 60.88 | 69.19 | | Revenue per employee (KRW 100M) | 9.0 | 8.9 | 9.0 | 8.1 | 8.5 | | Payroll as % of revenue | 6.4 | 6.5 | 7.5 | 7.5 | 8.1 | Data vendors disagree on headcount: Morningstar shows 345 and Simply Wall St 289. The DART-derived figure of 334 for FY2025 is preferred. Daeyoung Packaging is a mid-sized South Korean converter of corrugated board. It buys containerboard, about half of it from its own parent group, and turns it into corrugated sheets and finished corrugated boxes for industrial, consumer-goods and logistics customers. Its niche strength is heavy-duty multi-wall board, especially triple-wall pallet-type packaging. Vendor data put its share of the Korean market at roughly 7%. The company sits at the low-margin converting stage of the vertically integrated Daeyang Group value chain, behind Shindaeyang Paper's containerboard mills. As a result its earnings swing on the spread between containerboard costs and box selling prices. Operating margins fell from about 4% in FY2021–FY2023 to about 0.3% in FY2024–FY2025. Price increases in April 2026 helped produce a Q2 2026 rebound. The equity trades at roughly 0.3x book. It is now working to keep its KOSPI listing after the 2026 penny-stock rules forced a 5:1 consolidation. --- ### What the company does Daeyoung Packaging runs the two downstream stages of the corrugated packaging chain: 1. **Corrugating ("원단" / board sheets).** Containerboard (liner and medium) is combined on corrugators into single-wall, double-wall and triple-wall board sheets. 2. **Converting ("상자" / boxes).** Sheets are cut, creased, printed (flexographic, gravure and offset) and glued into finished boxes. The company also sells sheets to independent box makers ("지함소"). It does not make containerboard itself. Its raw material comes partly from group mills, mainly Shindaeyang Paper and Daeyang Paper (대양제지공업), and partly from third parties. In FY2025, purchases of raw materials and merchandise totalled KRW 201.4bn. Of this, KRW 98.3bn (48.8%) came from related parties such as Shindaeyang Paper and Daeyang Paper (Dealsite, 14 Apr 2026, citing the FY2025 business report). ### Company self-description (paraphrased from filings and company materials) Filings and company materials describe Daeyoung as a corrugated specialist founded in 1979 and listed in 1990. It produces corrugated board and boxes in one integrated process and ranks among the upper tier of the industry. It claims a leading position in triple-wall board. Its stated strategy is multi-product, high-quality production. It points to ISO quality and environmental certification and FSC chain-of-custody certification (StockPlus company summary drawn from filings). Recruitment materials list its range as double-faced single-wall (SW), double-wall (DW), two-layer medium board (DM), double two-layer medium board (DMB/DMA), triple-wall (TW), and flexo, gravure and offset printed boxes (Jobkorea company page). ### Revenue model | Revenue type | Share | Notes | |---|---|---| | Product sales: corrugated boxes | ≈53% (Q2 2026 YTD basis) | Made-to-order, customer-specific specifications | | Product sales: corrugated sheets | ≈35% | Sold to box converters and other users | | Other (merchandise, scrap/waste board, rental) | ≈11% | Includes resale of purchased goods and recycling of trim waste | | Service / subscription / licensing | 0% | None | Segment split per Butler (Q2 2026 revenue basis). Koala Gains separately reports standard corrugated boxes at about KRW 142.4bn, or roughly 51% of sales, for a recent year; the year was not specified. The business is almost entirely product sales on order. Corrugated packaging is made to each customer's specification, so finished-goods inventories are structurally small. The business is capital-intensive (corrugators, converting lines, printing equipment), and freight is a large cost: SG&A freight was KRW 14.1bn in FY2025, about 5% of revenue. ### Value-chain position Recovered paper (OCC) / pulp ↓ Containerboard mills (Shindaeyang Paper, Shindaeyang Paper Banwol, Daeyang Paper, third parties) ↓ CORRUGATED SHEET (원단) ← Daeyoung Packaging ↓ CORRUGATED BOX (상자) ← Daeyoung Packaging (and independent converters supplied by Daeyoung) ↓ Brand owners, manufacturers, agri/food, e-commerce & logistics Daeyoung is a downstream converter inside a vertically integrated group. KIRS (Nov 2024) noted a long-run profit gap in the industry. Containerboard mills earned a five-year average operating margin of 13.9% across the big five producers. Sheet and box operations earned only 3.4%. Daeyoung sits on the thin-margin side of that structure. ### Customers and end-markets Customer names and concentration are not publicly disclosed in the sources reviewed. Based on the product mix (multi-wall and pallet boxes, printed boxes) and industry structure, end-markets include: - Industrial goods, electronics and heavy items (triple-wall and pallet boxes) - Food, beverage and agricultural produce - Consumer goods and e-commerce/parcel logistics - Independent box converters (sheet sales) Export revenue is small. ### Independent characterisation Daeyoung is a commodity converter with modest scale, roughly one-third of the revenue of the industry leader Taelim Packaging. Its moat comes mainly from group membership: assured containerboard supply and shared logistics. Its standalone pricing power is weak. Profitability depends on the timing gap between containerboard price changes and box price changes. Containerboard increases typically reach sheet and box prices with a three-to-four-month lag (Dealsite, Apr 2026). The balance sheet is conservative, with equity of about KRW 192bn against liabilities of about KRW 68bn at end-2025. However, cash generation has recently trailed a heavy capex programme. Governance is family-controlled through the parent.

Revenue$0.2B
Employees334
Market CapN/A
Founded1979
Ansan, South Korea
DAE-IL

DAE-IL Corporation

Premium
Information Technology

DAE-IL Corporation (DIC) is a 50-year-old Ulsan-based precision powertrain component maker. It sits at Tier-1 and Tier-2 in Hyundai Motor Group's transmission supply chain, and Hyundai Transys alone is reported to account for roughly 62% of consolidated revenue. Its core competence is high-volume machining, heat treatment and assembly of gears and shafts. On that base it supplies internal-combustion and hybrid transmission parts (DCT, AT, light-car transmissions), EV reducers and shift-by-wire (SBW) components, plus transmissions and axles for forklifts and construction equipment. Production sites are in Korea (Ulsan and two domestic subsidiaries), China (Zhangjiagang) and the United States (Murray, Kentucky). Since 2019 management has tried to move the company from a cyclical, thin-margin ICE parts supplier toward e-powertrain, robotics actuators and reducers, rare-earth-free motors and small autonomous EVs (Zein Motors' Terian). That repositioning has made the stock a high-beta "robot/EV theme" name. Fundamentally, however, DIC remains a leveraged (debt-to-equity ~300%) auto-parts business with a 2–5% operating margin. --- ### What the company does DIC designs, machines, heat-treats and assembles power-transmission components, chiefly gears and shafts, and supplies them both as discrete parts and as sub-assemblies or complete units (transmissions, axles, reducers). Its own descriptions call it Korea's leading "Gear Maker" specialising in gears and shafts for power-transmission devices. Its 2019 IR mission statement was "To be the best powertrain maker in the world." Business activity falls into four buckets: 1. **Automotive parts (core; about 85–92% of revenue).** Gears, shafts and sub-assemblies for light-passenger-car transmissions, 6-speed sun gears, 7- and 8-speed dual-clutch transmissions (7DCT/8DCT), automatic and hybrid transmissions, EV reducers, SBW gear sets, electric oil pumps (EOP) and e-axle components. Customers include Hyundai Motor, Kia, Hyundai Transys, GM Korea and large module assemblers. 2. **Heavy-equipment parts (about 8–15%).** Transmission and axle assemblies for forklifts and construction equipment. The company describes itself as the exclusive supplier of finished forklift transmissions and axles to Doosan Bobcat Korea, HD Hyundai Site Solutions and Clark. 3. **E-mobility vehicles (subsidiary Zein Motors).** Small commercial EVs (the Calmato 1-tonne electric truck, launched 2019) and the Terian multipurpose electric utility vehicle, whose autonomous version launched in December 2025. 4. **New growth initiatives (pre-revenue or immaterial).** Cycloid and harmonic robot reducers, integrated robot actuators, rare-earth-free traction motors, an ESS battery with the in-house "Closer" fire-suppressant, battery recycling (affiliate Ecocell), and new materials R&D. ### Business model and revenue model Almost all revenue is product revenue from build-to-print and design-and-build component supply under multi-year vehicle-program awards. DIC has no material subscription, licensing or service income. Revenue tracks customer production volumes of specific transmission programs. Pricing is set per program, with periodic OEM price-downs and pass-through of some material costs. A 2019 example shows how Hyundai Group contracts work: in the "T-Project" with Hyundai Transys, Hyundai transferred 340 machines free of charge to DIC's Duseo plant, and DIC took over manual-transmission machining and sub-assembly for the 1-tonne Porter truck. The initial costs were expensed (about KRW 4bn) and recovered through unit pricing. ### Value-chain position DIC sits between steel and forging suppliers upstream and transmission and module makers (Hyundai Transys, Hyundai WIA, Dana historically) and OEMs (Hyundai, Kia, GM, Tesla) downstream. Its value-add is precision gear cutting, grinding and finishing (micron-level tolerances), heat treatment, and sub-assembly. Its China subsidiary added casting capability (foundry built 2008, second foundry 2011). ### Customer types and end-markets | End-market | Customers named in public sources | Notes | |---|---|---| | Passenger vehicles (ICE/HEV) | Hyundai Motor, Kia, Hyundai Transys, GM Korea | Hyundai Transys about 62% of consolidated revenue (FY2024, AlphaDistill citing FnGuide) | | EV drivetrain | Hyundai Motor Group (EV reducers), GM (Bolt EV parts, GMNA via SGM China), Tesla (EV reducer parts) | Asia Economy (2021) reported DIC as the exclusive supplier of EV reducers to Hyundai Group | | Light commercial | Hyundai (Porter manual transmission via T-Project) | — | | Forklifts / material handling | Doosan Bobcat Korea (formerly Doosan Industrial Vehicle), HD Hyundai Site Solutions, Clark | Described as exclusive supplier of finished transmissions and axles | | Construction equipment | HD Hyundai Construction Equipment, HD Hyundai Infracore (excavator parts) | Cited as a 2021 recovery driver | | China automotive (via subsidiary) | Hyundai WIA, Beijing Hyundai Dymos (Hyundai Transys China), Geely | 2018: Geely 53%, Hyundai Group 46% of the China subsidiary's sales | | Agricultural / utility vehicles | Farms, golf courses, Korea Post, logistics firms (Terian, Calmato) | Zein Motors | ### Company self-description vs independent characterization *Company framing (business-report summary, paraphrased):* a specialist in gears and shafts for power-transmission systems that has expanded from agricultural machinery parts into automotive, heavy-equipment and motorcycle parts. It is converting into an "electrification and autonomous-vehicle parts company" (reducers, SBW, EOP, e-axle) and was approved by Korea's Ministry of Trade, Industry and Energy as a flagship "business restructuring" company moving from ICE parts to future-vehicle parts. At its August 2026 50th anniversary, management restated the company as a "future technology company" spanning electrification, manufacturing AI transformation (AX), robotics and eco-friendly new materials. *Independent characterization:* DIC is a captive, mid-cap Hyundai-ecosystem gear machinist with heavy customer concentration, structurally thin margins (5-year average operating margin about 3.9%) and high financial leverage left over from the 2018–2020 China expansion and losses. Its EV reducer business is real and has a multi-OEM reference base (Hyundai/Kia, GM, Tesla). The robotics, rare-earth-free motor and autonomous-vehicle initiatives are early-stage options with immaterial revenue so far, yet they drive most of the share-price volatility. The investment case therefore depends on (a) Hyundai's hybrid and EV program wins (management cites about KRW 1.5tn of awards over five years), (b) ramp-up and profitability at Dae-il USA in Kentucky, and (c) deleveraging. The robot story is a secondary, high-variance option.

Revenue$0.5B
Employees695
Market CapN/A
Founded1976
Ulsan, South Korea
D'Ieteren/

D'Ieteren Group SA/NV

Premium
Information Technology

D'Ieteren Group is a 221-year-old, family-controlled Belgian investment company that has moved from its historic role as Volkswagen Group's Belgian importer to a focused holding of services and industrial distribution businesses. Its crown jewel is a 50.3% stake in Belron (Carglass, Safelite, Autoglass), the global leader in vehicle glass repair, replacement and ADAS recalibration. Belron generated €6.7bn of sales at a 22.9% adjusted operating margin in FY2025 and contributed 54% of Group adjusted PBT. Around it sit four other businesses: D'Ieteren Automotive, the Belgian VW Group distributor, now in cyclical decline and restructuring; PHE, a fast-growing French independent automotive aftermarket parts platform consolidating Spain and other markets; TVH, a 40%-owned global independent parts distributor for forklifts, construction and agricultural equipment; and Moleskine, a sub-scale notebook brand. Since the €74/share extraordinary dividend of December 2024, the Group runs a leveraged, cash-upstreaming model. A possible Belron IPO and a CEO change are the defining near-term catalysts. --- ### Company's own description | Business | Ownership | Accounting treatment | Company description (paraphrased) | |---|---|---|---| | Belron | 50.30% fully diluted economic rights | Equity-accounted (joint control with CD&R over reserved matters) | Worldwide leader in vehicle glass repair, replacement and recalibration | | D'Ieteren Automotive | 100% | Fully consolidated | Belgian distributor of Volkswagen, Audi, SEAT, Škoda, Cupra, Porsche, Bentley, Lamborghini, Bugatti, Rimac, Microlino and Maserati, expanding into other mobility services | | PHE (Parts Holding Europe) | 91% share capital; 100% economic rights under the anticipated-acquisition method | Fully consolidated | Leader in independent distribution of vehicle spare parts in Western Europe (France, Belgium, Netherlands, Luxembourg, Italy, Spain, Ireland) | | TVH | 40% | Equity-accounted (joint control with Wehold, the founding family holding) | Leading global independent distributor of aftermarket parts for material handling, construction and industrial, and agricultural equipment | | Moleskine | 100% | Fully consolidated | Develops and sells branded notebooks and writing, travel and reading accessories through a global multichannel platform | | D'Ieteren Immo | 100% | Fully consolidated (Corporate & Unallocated) | Holds the Group's Belgian real estate interests | In its FY-2025 results release and annual report profile, the company describes itself as an investment company. It says it has existed since 1805 across family generations. It seeks growth and value creation by building a "family of businesses" that reinvent their industries and pursue excellence and meaningful impact. It lists six holdings (FY-2025 press release, Note 1): ### Independent characterisation Economically, D'Ieteren is best understood as a levered, family-controlled holding with three layers: 1. **A world-class, high-margin services franchise (Belron).** Belron is a B2B2C service platform. Insurers and fleets are the main payers in most markets, and the motorist is the end user. Revenue comes from a service fee per job: windscreen repair or replacement, plus ADAS camera recalibration and value-added products and services (VAPS). The business has structural tailwinds. Windscreens are becoming more complex, carrying heads-up displays, sensors and acoustic layers. ADAS recalibration penetration rose from 36.4% in FY2023 to 47.2% in FY2025 and 52.1% in H1-2026. Belron is roughly 55% North America, 32% Eurozone and 13% Rest of World by sales (FY-2025 press release). 2. **Two industrial distribution platforms (PHE and TVH).** These are asset-light, inventory-intensive businesses. They earn a distribution margin on independent aftermarket parts. PHE serves car and truck repair garages, mostly in France (62% of FY2025 sales). TVH serves equipment owners and dealers globally. Both are buy-and-build consolidators with high-single-digit (PHE c.9%) and mid-teens (TVH c.13–16%) adjusted EBIT margins. 3. **A cyclical, legacy importer (D'Ieteren Automotive) and a sub-scale consumer brand (Moleskine).** D'Ieteren Automotive is a wholesale and retail distributor: it buys vehicles from VW Group and sells through independent and owned dealers. Its revenue is dominated by new vehicle sales (€3,976.6m of €4,978.7m in FY2025). Moleskine is a premium stationery brand with €117.8m sales and recurring impairments. **Revenue model mix (analyst characterisation, FY2025, sales Group's share €12,082.1m):** *Derived from FY-2025 press release Note 3 and segment sales (Belron at 50.3%, TVH at 40%). Percentages are analyst estimates and rounded.* **Value-chain position.** D'Ieteren sits downstream of manufacturers in every business. It is a distributor (vehicles, parts), a service provider (glass) or a brand owner using outsourced manufacturing (Moleskine). None of its businesses is a primary manufacturer. Customer types: insurers, fleet and leasing companies, motorists (Belron); independent garages and repairers (PHE); equipment dealers, rental companies and end users (TVH); dealers, fleets, leasing firms and consumers (D'Ieteren Automotive); retailers, corporates and consumers (Moleskine). End-markets: vehicle repair and maintenance (car parc–driven, largely non-discretionary), new car sales in Belgium (cyclical, policy-driven), industrial and agricultural equipment aftermarket (moderately cyclical), and premium stationery (discretionary).

Revenue$9.1B
Employees13,087
Market CapN/A
Founded1805
Brussels, Belgium
Cytogen

Cytogen, Inc.

Premium
Information Technology

Cytogen is a small-cap Korean precision-medicine company that began as a pure-play developer of circulating tumour cell (CTC) liquid biopsy technology. Its core asset is a proprietary high-density microporous (HDM) chip and the Smart Biopsy™ platform. The platform isolates CTCs from blood by size, without labels, and keeps the cells alive, so they can be cultured, single-cell sequenced and turned into organoids. Commercial traction from CTC services alone was minimal for a decade: revenue was below KRW 1.2 B in every year through 2022. Since a December 2023 change of control to the CanDx Holdings consortium, Cytogen has diversified through acquisitions. It bought a US CLIA/CAP toxicology lab (ExperTox) in January 2023 and Korea's self-described number-one NIPT/PGT provider (Genomecare) in August 2024. It has also added medical-device distribution. Revenue reached KRW 26.1 B in FY2025, but the company remains loss-making. Management now presents Cytogen as a "life-cycle precision medicine" platform spanning fertility genomics, cancer diagnostics and an early-stage anti-metastasis drug programme. --- ### The company's own description In its periodic reports, Cytogen describes itself as a CTC-based liquid biopsy platform company. It uses proprietary "Live CTC" isolation technology to provide biomarker analysis and companion-diagnostic assay development for pharmaceutical companies developing oncology drugs (Q1 2026 quarterly report, as summarized by ValueLine). The same filing summary lists the main activities: - CTC analysis services for pharmaceutical companies on the Smart Biopsy™ platform - Data provision and kit supply for research institutions - Precision-medicine diagnostic services - Global expansion through the acquisition of a Texas CLIA lab and the establishment of a Japanese subsidiary - Diversification into medical-device distribution and health-functional-food sales - Acquisition of the prenatal/postnatal diagnostics company Genomecare in 2024, to secure stable cash flow The Q1 2026 quarterly report states that the August 2024 Genomecare acquisition, which covers PGT and NIPT across the journey from IVF to delivery, "improved cash flow and strengthened consolidated financial results" (KIND, Q1 2026 quarterly report extract). In July 2026, explaining the Genomecare merger, the company said it now has two core businesses: - CTC-based precision medicine, framed as the future growth engine - Prenatal and pre-implantation genetic testing, which already generates stable profits The stated ambition is to become a "full life-cycle precision medicine company", from pre-implantation genetic testing through prenatal diagnosis to cancer precision diagnosis and treatment support (Seoul Economic Daily / SEN TV, 29 July 2026). ### Business model and revenue model | Revenue stream | Model type | Description | Approximate share | |---|---|---|---| | Genome technology development and analysis services (Genomecare: NIPT, PGT) | Fee-for-service diagnostics, mostly B2B2C via fertility and obstetric clinics | Per-test fees for non-invasive prenatal testing and pre-implantation genetic testing | ~47% of revenue (Q2 2026 basis) | | Liquid biopsy application business | Mixed: services (B2B pharma contract analysis; Japanese premium out-of-pocket tests), product sales (Smart Biopsy™ instruments, chips, kits), equipment contracts (e.g. digital lab-on-chip automation system), plus distribution of medical devices and health-functional food | CTC enumeration and characterization, drug-efficacy evaluation, CDx assay development; Japan CTC services; distribution | ~48% (Q2 2026 basis) | | Toxicology and molecular diagnostics (ExperTox, Houston, Texas) | Fee-for-service laboratory testing | CLIA/CAP-accredited toxicology testing for 100+ US hospitals and labs | ~6% (Q2 2026 basis) | | Licensing / royalties | Not a material disclosed stream | Out-licensing of anti-metastasis candidates is contemplated, not yet realized | 0% | Cytogen's revenue model has four layers: The segment mix is from the Butler.works summary of DART filings ("Liquid Biopsy application 48% · Genome technology development and analysis service 47% · Toxicology and molecular diagnostics 6%", 2026 Q2 revenue basis). The shares sum to 101% because of rounding at source. Two points stand out. First, a large portion of the "Liquid Biopsy application" segment appears to consist of low-margin distribution revenue rather than CTC technology revenue. Medical-device distribution (for example, medical gloves) generated KRW 1.5 B in Q3 2024 alone (thebell, March 2025). Second, the precise split between CTC services, equipment and distribution inside that segment is not publicly disclosed in accessible summaries. ### Value-chain position **CTC business:** Cytogen sits upstream as a platform developer and instrument maker (HDM chip, isolator, stainer, imaging analyser). It sits midstream as a GCLP-certified central lab offering analysis services. In Japan it is beginning to move downstream into patient-facing (B2C) out-of-pocket testing through hospital partners such as Japan's National Cancer Center Hospital. **Genomecare:** A downstream clinical laboratory service provider. It receives samples from fertility clinics and obstetricians and returns NGS/AI-based genetic reports. **ExperTox:** A downstream US reference laboratory. ### Customer types and end-markets | Customer type | Examples (disclosed) | End-market | |---|---|---| | Global and domestic pharma/biotech | Daiichi Sankyo (2018 AXL biomarker research); pharma clients in Japan via CMIC marketing agreement | Oncology drug development (biomarkers, CDx) | | Hospitals / academic medical centres | Samsung Medical Center, Asan Medical Center, Seoul National University Hospital, Seoul St. Mary's, Severance, Gangnam Severance; Japan NCCH | Clinical research, precision oncology | | Government / research institutes | US NIH (platform supply, 2022); Gangwon Regional Public Procurement Service (2025 automation-system contract) | Research infrastructure | | Fertility clinics and obstetricians (Genomecare) | Described as "top fertility hospitals nationwide" (names not disclosed) | Reproductive genomics (NIPT, PGT) | | US hospitals and labs (ExperTox) | 100+ hospitals and labs in Houston, Texas | Toxicology testing | ### Independent characterization On the evidence, Cytogen is not a scaled CTC diagnostics company. It is a holding-like small cap whose consolidated revenue is now driven by an acquired reproductive-genomics lab and by distribution activities. That revenue funds a sub-scale but technically differentiated CTC platform and a newly announced drug-discovery venture. The NIPT/PGT unit is genuinely profitable: FY2025 standalone operating margin was about 27%. It is the economic anchor. The CTC franchise has struggled for more than a decade to convert scientific credibility into recurring revenue. That credibility includes NIH platform supply, Japanese NCCH collaboration and AACR presentations. The strategy pursued since 2024 under CanDx-aligned management (portfolio diversification, bio-robotics, PRP automation, anti-metastasis drugs) widens the scope considerably relative to the company's balance sheet. The repeated governance conflicts between the founder and the controlling shareholder are a distinctive feature of the investment case.

Revenue$0.0B
Employees43
Market CapN/A
Founded2010
Gwacheon, South Korea
CyberOne

CyberOne Co., Ltd

Premium
Information Technology

CyberOne is a Seoul-based, founder-controlled pure-play cybersecurity services company whose core is labour-based managed security services (security monitoring, or "보안관제") operated from its own security operations centre, complemented by government-recognised security consulting (vulnerability assessment of critical information infrastructure, ISMS and privacy impact assessments), integration and maintenance ("smart systems"), and a modest portfolio of in-house products under the PROM brand. It holds the Ministry of Science and ICT designation as a security monitoring specialist, which is a gating credential for public-sector monitoring contracts. Since August 2023 it has controlled Xcurenet, a 1990s-founded data-loss-prevention vendor whose AI-based EMASS network leak-detection product produced an exceptional, lumpy solution year in 2024. With FY2025 revenue of KRW 33.7bn, a debt-free balance sheet holding roughly KRW 20bn or more in cash and short-term instruments, and a market value near KRW 30bn, CyberOne is a micro-cap that trades at a discount to book. --- ### What the company does CyberOne describes itself in its quarterly filing as a comprehensive information security company founded in 2005 that runs security monitoring, security consulting, smart systems and security solutions businesses, with consolidated reporting that includes subsidiary Xcurenet [S19]. Independent research (Korea IR Council, November 2024) describes six business lines including the subsidiary, and a business focused on monitoring, consulting, smart systems, security solutions and cloud services [S6]. The operating model in each line: **Security monitoring (managed security services, MSS):** Customers' firewalls, intrusion detection/prevention systems, anti-virus and other controls are operated and watched remotely, 24×365, from the CyberOne control centre (branded "SecuCenter" in company materials), with incident response, reporting and vulnerability checks bundled in [S17][S36]. A second delivery mode, common in Korea's public sector, places dispatched staff on customer premises to run integrated monitoring rooms (for example, the 2015 wins at the Korea Education and Research Information Service and the Daegu and Ulsan city governments) [S17]. Cloud monitoring for AWS and Azure workloads was added around 2020 [S22]. **Security consulting:** Information security management system (ISMS) consulting, critical information infrastructure (CII) vulnerability analysis and evaluation, privacy impact assessments (CyberOne was designated a PIA agency in 2012), vulnerability diagnosis and cloud security maturity assessments such as "Cloud SE for AWS" [S17][S22]. A February 2026 contract for CII protection consulting across local governments illustrates this line [S14]. **Smart systems:** Integration, build-out and maintenance of security systems; recorded mainly as service revenue (maintenance) with some merchandise [S5][S17]. **Security solutions:** Proprietary products (PROM SIEM integrated security log management, PROM ATS, the PROM MFIT C1-1000 appliance) and third-party resale [S17]. **Cloud services:** Security-as-a-service offerings such as the "WebShield" web application firewall and managed cloud security, sold with partners such as NAVER Business Platform (MSP partnership) and Cloudmate [S17][S22]. **Xcurenet (subsidiary):** Develops and sells AI-based network data-loss-prevention and information-leak detection software (Venus/EMASS AI family) and, from 2026, generative-AI security and endpoint-agent products [S20]. ### Revenue model | Period | Services % | Products % | Merchandise % | Source | |---|---|---|---|---| | 1H 2024 | 90.1 | 7.2 | 2.7 | KIRS, citing 1H24 business report [S6] | | 9M 2024 (cumulative) | 81.1 | 17.2 | 1.7 | SR Times [S10] | | 1Q 2026 | 95 | 4 | 2 | JobKorea (NICE data) [S17] | | 1H 2026 (cumulative) | 85 | 11 | 4 | Butler, citing 2Q26 report [S5] | Revenue is classified in filings as services (용역), products (제품) and merchandise (상품). Services dominate: The services line (monitoring, consulting, cloud and maintenance) is predominantly multi-year or annually renewed contract revenue; Kiwoom reported 780 customers and a 93% renewal rate in 2021 [S7]. Product revenue is largely Xcurenet licence/appliance sales, which are concentrated in the fourth quarter [S11]. There is no disclosed subscription/ARR metric. ### Value-chain position, customers and end-markets CyberOne sits at the service-delivery end of the Korean security value chain: it operates and assesses other vendors' controls rather than primarily selling its own technology. Regulatory designations (security monitoring specialist; information-protection consulting specialist; PIA agency) function as licences to bid on public-sector work [S6][S17]. End-markets are public institutions (central and local government, education, public broadcasters), financial services and private enterprises. Examples in disclosures include the regional informatisation agency for local governments (via the Public Procurement Service) and Korea Educational Broadcasting System (EBS) [S14][S16]. Export revenue was about 4.7% of FY2025 revenue [S2]. ### Independent characterisation CyberOne is best understood as a people-based managed-services firm with an option on software. Its standalone economics resemble an IT-services contractor: payroll equalled 43.5% of standalone revenue in FY2025 (KRW 12.3bn of KRW 28.2bn) [S4], standalone operating margins have ranged from about 2% to 8%, and revenue per employee is about KRW 110m [S4]. The Xcurenet acquisition introduced a software asset with very different, highly volatile economics (45% implied margin in FY2024, loss in FY2025). The result is a group whose reported earnings are dominated by the timing of a few solution deals, while the underlying services franchise grows in single digits.

Revenue$0.0B
Employees256
Market Cap$0.0B
Founded2005
Seoul, South Korea
Curexo

Curexo Inc.

Premium
Information Technology

Curexo is South Korea's most established listed orthopedic surgical-robotics company. It sits inside the hy (formerly Korea Yakult) group, which has controlled it since 2011. Its main product is CUVIS-joint. This is an "active" robot that plans from CT scans and cuts bone automatically for total knee arthroplasty. It now also covers hips (CUVIS-joint THA). In March 2026 it received US FDA 510(k) clearance, and it holds EU CE MDR certification. Two other robots complete the line: CUVIS-spine, for pedicle-screw guidance, and Morning Walk, a gait-rehabilitation robot. Around the robots sit two cash-generating businesses. The first distributes orthopedic implants (Zimmer Biomet NexGen and Exactech shoulder). The second is a food-ingredient trading business that sells mainly to group-related customers hy and Paldo. FY2025 revenue reached a record KRW 74.5bn, and operating profit returned at KRW 2.4bn. Even so, Curexo remains a sub-scale player in a market led by Stryker, Zimmer Biomet, Smith+Nephew and J&J. Its differentiation rests on full automation, an open implant library, and pricing aimed at emerging markets. --- ### The company's own description Curexo's filings and investor materials describe three businesses. The medical robot business develops, makes and sells CUVIS-joint, CUVIS-spine and Morning Walk. The implant business distributes orthopedic implants. The trade business imports and sells food raw materials. (Sources: FY2025 business report summary via Valueline, 1Q26 update; Sangsangin Securities NDR deck, Mar 2025.) The company describes CUVIS-joint as an active surgical robot. It plans from CT images and uses a six-axis vertical articulated arm to cut bone automatically. The robot is supplied to Korean general and specialty hospitals and exported to India, Malaysia, Indonesia, Japan and other markets. CUVIS-spine guides pedicle-screw insertion using C-arm and O-arm imaging and lowers radiation exposure. In implants, Curexo runs the Korean master distributorship for Zimmer Biomet's NexGen knee system. In 2025 it added exclusive Korean rights to Exactech's shoulder implants. The trade business imports ingredients such as chicory dietary fibre and crystalline fructose, used in fermented milk and ramen. Its principal customers are hy Co., Ltd. and Paldo Co., Ltd. (Source: FY2025 business report summary via Valueline.) ### Business and revenue model | Revenue stream | Model | Notes | |---|---|---| | Robot system sales | One-time capital equipment sale | Equipment estimated at KRW 200–500 million per unit (SK Securities, May 2025) | | Robot consumables and service | Recurring, procedure-linked | Revenue comes from robot sales plus consumables; the company points to installed-base pull-through (THE VC analysis; CEO comments, Kukinews Sep 2022) | | Distributor sales (exports) | Wholesale to local distributors | India (several distributors since 2025), Japan (Kyocera), Egypt (distributor contract 2026) | | Implant distribution | Resale margin on third-party implants | Described as the most profitable segment by margin (The Bell / Money Today, Mar 2025) | | Trade | Import-and-resell margin on food ingredients | Mostly sold to hy and Paldo. In FY2024, hy (KRW 10.7bn) and Paldo (KRW 14.9bn) were each disclosed as customers above 10% of sales (The Bell, Mar 2025) | | Subscription or licensing | Not publicly disclosed as a material stream | — | ### Value-chain position, customers and end-markets **Value chain.** Curexo is an original equipment manufacturer for its own robots. It handles design, software (including AI-based surgical planning), assembly, regulatory work and training. It buys precision components externally. Examples include an actuator-supply MOU with SPG (Mar 2026) and earlier cost-reduction work with Neuromeca (Korea Investment & Securities, May 2024). In implants and trade, it is a distributor. **Customers.** - Korean tertiary and specialty hospitals (robots, implants). - Overseas distributors and hospital groups (India, Japan, Southeast Asia, Egypt). - hy and Paldo (trade). **End-markets.** - Orthopedic joint replacement (knee, hip) - Spine surgery - Neurological and stroke gait rehabilitation - Orthopedic implants (Korea) - Processed-food ingredients (Korea) ### Independent characterization Curexo is best described as a hybrid. It is an early-commercial surgical-robot developer, funded and stabilized by two low-growth but cash-generative distribution businesses. **Revenue quality:** In FY2023, the robot segment was about 47% of sales and trade about 40% (NH Investment & Securities, Jan 2025). The robot segment fell to about 35% in FY2024 when the Indian channel broke down (Kiwoom, Jan 2026). In Q2 2026 it rose to about 53% (Butler, citing the H1 2026 report). **Profitability:** It depends on robot volume. The robot segment lost about KRW 7bn in FY2024 and earned only KRW 1.3bn in FY2025 (Hankyung, Jul 2026). Group profitability therefore still leans on implants and trade. **Strategic thesis:** The core bet is that a fully autonomous, open-platform knee and hip robot can win share in price-sensitive emerging markets (India, Southeast Asia, Middle East and Africa, Latin America) and in Japan. US and EU clearances in 2026 provide credibility but not yet revenue.

Revenue$0.1B
Employees107
Market CapN/A
Founded1992
Seoul, South Korea
CUCKOO

CUCKOO Homesys Co., Ltd

Premium
Information Technology

CUCKOO Homesys is the rental and environmental-appliance arm of Korea's Cuckoo group. It is best known for water purifiers sold under the "Inspure" (인스퓨어) brand, together with bidets, air purifiers, mattresses, induction cooktops and a widening range of small and mid-sized appliances. The company sells through two routes: monthly rental contracts bundled with visiting maintenance service, and outright or finance-lease sales. Under K-IFRS the outright and finance-lease sales are booked largely upfront. In FY2025 it generated consolidated revenue of ₩1,121.3bn and operating profit of ₩169.4bn (15.1% margin). It had about 3.28 million domestic rental accounts in Q1 2026 and roughly one million in Malaysia. Its Malaysian subsidiary, CUCKOO International, has been listed on Bursa Malaysia since June 2025. The company is Korea's second-tier challenger to the market leader Coway. It is financially conservative (net cash, debt-to-equity about 25%) but trades at a deep discount (P/B about 0.46x) because of slowing overseas growth, governance concerns and thin R&D. --- **Company self-description (as summarised from filings and press).** In its regular filings and in press summaries of them, the company describes itself as a manufacturer and seller of household environmental appliances: water purifiers, air purifiers, bidets and related products, components and materials. It sells these on both a lump-sum and a rental basis. Domestically, it says it has built a nationwide rental distribution network. This network includes its own rental branches and offices and a rental business headquarters, plus rental specialist shops, door-to-door sales specialists, electronics retailers and discount stores. Overseas, it sells on lump-sum and rental terms in Malaysia, India, Indonesia (Indonesia was later transferred out) and the United States (Newsquest, 2022, summarising the business report). Morningstar's profile classifies the company under Rental & Leasing Services. It describes the products as kitchen, healthcare and living appliances, including electric pressure cookers, blenders, water purifiers and heaters. **Independent characterisation.** CUCKOO Homesys is best understood as a hybrid hardware-plus-service subscription business. Four features stand out. 1. **Revenue recognition makes it look like a product company.** Many of Cuckoo's long-term rental contracts are classified as *finance leases*. Under K-IFRS, the present value of the contract is recognised largely upfront as product ("lump-sum", 일시불) revenue. Only the residual service element and operating-lease contracts are booked as rental revenue. As a result, disclosed rental revenue was only 22.3% of H1 2026 revenue at Cuckoo, against 91.4% at Coway. On a like-for-like basis, News1 (Aug 2026) estimated the gap at 84% vs. 91%. Butler.works' segment split for Q2 2026 shows Appliances 79% / Rental 21%. 2. **The domestic rental base is still growing.** Cumulative domestic rental accounts rose from 3.03 million in Q1 2025 to 3.28 million in Q1 2026 (+8.3%) (Datanews, Jun 2026). Historical growth: 1.45 million total accounts in 2017 (1.20m domestic, 0.25m overseas); 1.95 million in 2018; 2.41 million in 2019 (1.58m domestic, 0.83m overseas) (iNews24, 2020). 3. **Overseas means Malaysia.** About 89% of overseas revenue comes from the Malaysian subsidiary (AlphaDistill, Jun 2026 — an aggregator; consistent with Datanews figures). In 2025, Malaysia's ₩363.9bn was about 90% of ₩405.8bn total overseas revenue (derived from Datanews, Sep 2026). The US, India and Singapore subsidiaries have been loss-making and in full capital impairment (Edaily, Jun 2025). 4. **It sits inside a controlled group.** CUCKOO Holdings owns 40.55%, and CEO Koo Bon-hak personally owns 20.53% (Dealsite, Jan 2025). Related-party sales were ₩27.4bn in 9M 2024 (+27.4% YoY) (Dealsite, Jan 2025). CUCKOO Holdings' manufacturing subsidiary, Cuckoo Electronics, makes the group's rice cookers and kitchen appliances. Homesys focuses on rental and "clean" appliances. **Business model and revenue model mix.** **Value-chain position.** Cuckoo designs the products and sources key components, for example compressors (multi-sourced) and fittings from suppliers such as Stormtech. Stormtech counts Coway and Cuckoo Homesys among its top four customers (Alphasquare/Stormtech IPO brief, Jun 2025). Cuckoo then distributes and services the products directly. Products sold in Malaysia are all Korean-made (NewDaily, Jun 2025). The company owns the customer relationship through installation, filter delivery and "care manager" visits. For example, filter change intervals are 8 months for the pre-carbon block, 12 months for the natural filter and 20 months for the RO filter on the Inspure large-capacity model (Rentre product page). **Customer types and end markets.** Mainly households (B2C), with some offices and commercial users (large-capacity groundwater and commercial purifiers). In India the subsidiary has added B2B water and air purifier sales (Newsis via FNNews, Mar 2022). End markets: Korean household environmental appliances (water, air, bidet, sleep, kitchen); Malaysian/Singapore/Brunei home appliance rental through CKI; and the Korean-American community and broader US market through CUCKOO Rental America.

Revenue$0.8B
Employees1,037
Market CapN/A
Founded2017
Siheung, South Korea
Cuckoo

Cuckoo Holdings Co., Ltd.

Premium
Information Technology

Cuckoo Holdings is the listed apex of Korea's Cuckoo group. In legal form it is a holding company under the Monopoly Regulation and Fair Trade Act. In economic substance it is a wholly-owning operator of Korea's dominant electric rice-cooker franchise. Its 100% subsidiary Cuckoo Electronics holds roughly 70% of the Korean rice-cooker market and has extended the brand into induction ranges, food-waste disposers, kimchi refrigerators, dishwashers, humidifiers and other small and mid-sized kitchen and living appliances. Overseas sales companies in China, Vietnam, the US, Malaysia, Indonesia and Australia make up just over one-fifth of revenue. Alongside this operating core, the company owns 40.55% of listed rental affiliate Cuckoo Homesys, which it equity-accounts. That stake contributes about a third of pre-tax profit. The balance sheet is net-cash, payouts are rising, and valuation is very low (about 5x trailing P/E, 0.6–0.7x P/B). Governance questions — family control, treasury-share use and board independence — remain the main debate. --- ### Company's own description In its disclosures (as summarised by vendors from the Business Report), the company describes itself as a holding company created in December 2017 through a human split and a physical split. Its stand-alone revenue comes from four streams: trademark royalties from the brand user, management-advisory fees, dividends from subsidiaries, and real-estate rental. Its principal subsidiary, Cuckoo Electronics, manufactures and sells kitchen and living appliances centred on electric rice cookers: IH pressure, hot-plate pressure and electric warmer cookers. The lineup is widening into electric ranges, humidifiers and food-waste disposers. The company cites about 70% share of the domestic rice-cooker market and 20 consecutive years at the top of customer-satisfaction rankings. It says it runs three production plants in Yangsan (South Gyeongsang) and Siheung (Gyeonggi). It distributes through sales offices, directly-run specialty stores, mass merchandisers, home shopping and online, and is expanding in China, Vietnam and the US [S58][S4]. ### Independent characterisation **Economic substance:** Consolidated P&L is almost entirely Cuckoo Electronics plus overseas sales subsidiaries. Holding-company revenue (royalties, fees, rent) is eliminated on consolidation. Stand-alone revenue was KRW 58.8 bn in FY2025, including dividends [S33]. Cash moves from Cuckoo Electronics to the parent without passing through another listed layer, unlike most Korean holding structures [S50-type commentary in VIC analysis, S66]. **Two value engines:** - (i) The manufacturing and branded-sales business: FY2025 revenue KRW 920.9 bn, operating income KRW 114.0 bn [S1]. - (ii) The 40.55% equity stake in Cuckoo Homesys (rental and lump-sum sales of water purifiers, air purifiers, bidets, mattresses), booked as equity-method income of KRW 51.2 bn in FY2025, or 27.8% of pre-tax profit [S1][S24]. **Revenue model:** Predominantly one-time product sales, both manufactured goods and purchased merchandise. In 2024 Cuckoo Electronics reported product sales of KRW 528.4 bn and merchandise sales of KRW 189.8 bn [S62]. Recurring subscription and rental economics sit at Homesys, outside the consolidation perimeter. Licensing income (brand royalties) exists at the parent level but is intra-group. **Value-chain position:** Vertically integrated designer, manufacturer and brand owner. Domestic plants handle core rice-cooker production. A rising share of outsourced or ODM merchandise supports category extensions: merchandise inventory rose from KRW 37.0 bn to KRW 65.8 bn during FY2025 [S1]. A Chinese production base ("Zhongshan campus") serves the China market [S17]. **Customers and channels:** Korean households, plus Korean-diaspora and mainstream consumers abroad. Channels are omnichannel: own stores and sales offices, mass merchandisers, home shopping, e-commerce (Naver Shopping Live in Korea; JD, Tmall and TikTok in China; Amazon and Costco in the US), and B2B commercial dishwashers [S17][S28][S31][S53]. **End-markets:** Small kitchen appliances (rice cookers, ranges, blenders, air fryers, microwaves); living and environmental appliances (humidifiers, vacuums, food-waste disposers); select large appliances (kimchi refrigerators, freezers); and personal-care appliances (Re:Nature hair dryers) [S35][S28][S60].

Revenue$0.6B
Employees82
Market CapN/A
Founded1978
Yangsan, South Korea
CubicKorea

Cubic Korea Inc.

Premium
Information Technology

Cubic Korea is a small-cap Korean automotive-parts group built on hydrographic (water-transfer) "curved-surface printing." The process applies wood-grain, carbon, metallic and other patterns to three-dimensional plastic, metal and urethane components. The parent company in Ansan entered the business under a licence for the Curl-Fit process developed by Japan's Dai Nippon Printing (DNP) and Cubic Co. It has since developed its own process variants and patents, and it supplies decorated interior trim and steering-wheel components mainly to Hyundai Motor Group's tier-1 supply chain. Since 2009, its wholly owned subsidiary Samshin Chemical Industry (삼신화학공업) has added injection moulding, plating and painting of exterior parts such as radiator grilles, mouldings and emblems. Exterior parts now generate about 89% of group revenue. The company is a controlled affiliate of chemicals distributor Samyung Trading. It trades at roughly 0.3x book value with a dividend yield above 5%, while revenue and margins have been declining since 2024. --- ### What the company does Cubic Korea operates in surface treatment and the manufacture of automotive interior and exterior components. Its core technology is hydrographic transfer, which Korean filings call 수압전사 or "curved-surface printing." In the Curl-Fit method described in NICE 2020, a polyvinyl alcohol (PVA) film printed with a pattern is floated on water, and an activator dissolves the film. The part is then dipped through the floating ink layer, and water pressure wraps the pattern around complex 3D geometry. Pre-treatment, base-colour painting, washing, film removal, drying and a protective clear coat follow. The technique can decorate ABS, PS, PVC, PP, aluminium and other substrates. The company states it has extended it to metals, ceramics and glass. NICE 2020 lists four proprietary process variants: **Double (multi-film) transfer:** layers two films for greater depth and colour range. **Hydro-pad transfer:** combines hydrographic transfer with pad printing to add tactile texture. **Plating + hydrographic transfer:** produces high-brightness carbon and metallic effects that paint alone cannot achieve. **Exterior hydrographic transfer:** uses a dedicated exterior-grade coating, extending hydrographics from interiors to side mirrors and B-pillars. The subsidiary Samshin Chemical Industry, founded January 1975 and 100% owned since June 2009, makes exterior parts through plastic injection, plating and painting. NICE 2020 names its products as emblems, mouldings and radiator grilles, supplied for Hyundai, GM Korea, Renault Samsung (now Renault Korea) and Mazda vehicles. ### Business and revenue model Cubic Korea is a product manufacturer and contract processor. It has no disclosed subscription, licensing-out or service revenue. **Parent (Cubic Korea Inc.):** mostly processing revenue. It applies hydrographic and painted finishes to injection-moulded parts supplied by Samshin or by tier-1 vendors, then delivers finished parts back into the tier-1 chain. Parent-only revenue was KRW 28.8 bn in FY2025 (DART FY2025 BR via ETFshopping), about 12.7% of consolidated revenue before eliminations. **Subsidiary (Samshin Chemical Industry):** sells finished exterior components. Total assets were KRW 122.9 bn and net income KRW 1.42 bn in its latest fiscal year (DART FY2025 BR via ETFshopping). **Revenue mix:** automotive exterior parts 89%, automotive interior parts 11% (2Q 2026 revenue, butler.works citing company disclosures). Revenue is won through model-by-model competitive tenders run by Hyundai Motor and Kia (KFTC 2026). Revenue therefore depends on vehicle-programme wins, programme life cycles and OEM production volumes. Pricing terms are not disclosed. ### Value-chain position The parent is effectively a tier-2 surface-treatment specialist. It decorates parts on behalf of tier-1 module and trim suppliers serving Hyundai Motor Group. Samshin works at the tier-1/tier-2 boundary as a moulder, plater and painter of exterior trim. Raw-material inputs include ABS injection parts, hydrographic films, paints and plating chemicals. The Haman plant registration lists PVC processing with ABS mouldings as raw material (factory registry via ifactoryhub.com). ### Customers and end markets **Automotive (core):** Hyundai Motor, Kia, GM Korea and Renault Samsung (named in NICE 2020), plus Mazda through Samshin. The KFTC 2026 decision confirms that Hyundai/Kia tenders are the main channel; Cubic won the Palisade (LX2) interior surface-treatment programme in the tender round investigated. - **Home appliances and consumer goods (historical, scale not disclosed):** NICE 2020 lists Samsung Electronics, LG Electronics, Woongjin Coway and Angel Musical Instruments as customers for appliance casings, refrigerator handles, washing-machine control panels, microwaves, vacuum cleaners and musical instruments. Current revenue from these products is not disclosed. The 89/11 split suggests it is now immaterial or reported inside the segments. **Diversification targets (stated 2020):** mobile phones, water purifiers, computers, musical instruments, building materials, furniture, sporting goods and cosmetics containers (NICE 2020). No subsequent revenue disclosure was found. ### Company's own description versus independent characterisation **Company/S&P description (paraphrased):** Cubic Korea describes itself as a curved-surface printing business in Korea and abroad. It applies printed patterns to moulded plastic, aluminium, metal and urethane parts, and develops and produces automotive exterior and interior parts including radiator grilles, mouldings, steering wheels, wheel caps and emblems (S&P/StockAnalysis profile, Oct 2026). **Independent characterisation:** Despite its "printing" identity, Cubic Korea is now mainly a domestic automotive exterior-trim supplier, because nearly nine-tenths of revenue comes from Samshin's exterior parts. The hydrographic franchise the company is named for is a small, specialised and historically near-monopolistic niche inside Hyundai/Kia's interior supply chain. The KFTC found that Cubic and SM Hwajin together held 100% of the tenders examined. The group is a price-taker toward a dominant customer group, operates at thin margins (3–5% operating margin), and is exposed to Korean domestic auto production volumes and Hyundai/Kia programme cycles.

Revenue$0.2B
Employees125
Market CapN/A
Founded1989
Ansan, South Korea
CTRMobility

CTR Mobility Co., Ltd.

Premium
Information Technology

CTR Mobility is a Korean Tier-1/Tier-2 maker of precision-machined drivetrain components and suspension parts, with a lightweight aluminium-forged sub-business. It is a captive-proximity supplier to Hyundai Motor Group. Plants in Ulsan, Seosan and Daegu sit next to the Hyundai, Kia, Hyundai Mobis, Hyundai Transys and Hyundai WIA facilities they serve, and Hyundai Motor Group took more than 90% of sales in the last disclosed customer split. The company was first in Korea to localise automotive ball screws and to mass-produce forged aluminium control arms, which it has supplied to Tesla. That technology earned a "Tesla supplier" market narrative after the 2019 IPO. Operationally, FY2025 revenue reached a record KRW 461.5 bn. Profitability, however, is thin (1.3% operating margin) and is consumed by interest on a short-dated debt stack. The company has booked three consecutive annual net losses (FY2023–FY2025). The equity story is now dominated by three issues: owner succession to third-generation Vice Chairman Kang Sang-woo, an unfunded KRW 1 tn 2030 revenue ambition, and a market capitalisation below the KOSPI KRW 30 bn listing floor. --- ### What the company does CTR Mobility manufactures automotive powertrain/drivetrain and chassis/suspension components, mainly for Hyundai Motor Group vehicles. Its products fall into two reported business lines [S1], [S6]: **Drivetrain parts (구동부품):** rotor shafts, inner races, OD (overdrive) clutch bosses, sleeve gears, ball screws and propeller shafts. These made up about 64% of FY2025 revenue, according to DealSite's reading of the FY2025 annual report. A separate DealSite article in the same series gives "about 65%" [S1], [S3]. In Q2 2026 the drivetrain share fell to 59% [S6]. **Suspension parts (현가부품):** axles and control arms, including forged aluminium control arms. These made up about 36% of FY2025 revenue, passed 40% for the first time in Q1 2026, and reached 41% in Q2 2026 [S1], [S3], [S6]. ### Company's own description Recent exchange and portal filings describe the company as a specialist producer of automotive driving devices (구동장치) and suspension devices (현가장치) [S9]. It is classified under "other new automotive parts manufacturing" (그 외 자동차용 신품 부품 제조업) [S9]. At the April 2023 rename, management framed the company's vision as becoming "Central to your safe mobility": a supplier of safe products and services for all forms of transport [S11], [S12]. The same launch introduced the "BEYOND 3015" growth plan. The verbatim risk-factor and business-description text of the FY2025 annual report (filed 18 March 2026) could not be retrieved; the description above is drawn from secondary reproductions of DART data. ### Business and revenue model **Revenue model:** Almost entirely product sales of OEM production parts under supplier nomination agreements. No service, subscription or licensing revenue is disclosed. Small "other" sales (1.0–1.8% in 2018–2020) appear in older broker splits [S17], [S18]. **Pricing:** OEM part pricing is negotiated with each vehicle maker and not disclosed. The domestic Korean parts industry typically works under annual price-down and raw-material pass-through arrangements, but CTR Mobility's specific terms are not publicly disclosed. **Value-chain position:** A component manufacturer that supplies (a) module and system makers (Hyundai Transys for transmissions, Hyundai Mobis for modules, Hyundai WIA for drivetrain and axles) and (b) vehicle assemblers directly (Hyundai Motor, Kia contract plants). It also exports to overseas OEMs, historically Tesla, GM, Renault and BMW [S1], [S17]. **Customer types:** Captive-group OEM and Tier-1 customers dominate. In H1 2020, the last disclosed customer split, Hyundai Motor Group took 91.3% of sales and overseas customers 8.7% [S17]. About 70% of Seosan plant sales go to Hyundai Transys [S1]. **End-markets:** Light vehicles across ICE, hybrid (HEV) and battery-electric (BEV) powertrains. Drivetrain parts such as rotor shafts, inner races and propeller shafts are tied to transmission and engine/motor driveline architectures. DealSite's analysis concludes this business gains from the current HEV/BEV transition period and could shrink as pure-BEV penetration rises [S3]. Suspension parts are powertrain-agnostic and benefit from vehicle lightweighting [S3], [S17]. ### Independent characterisation CTR Mobility is a mid-sized, low-margin, Hyundai-centric precision-machining house with one differentiated technology franchise: aluminium forging for lightweight control arms, now housed in its 100% subsidiary CTR EcoForging. It also has an early-stage niche in ball screws for electrified actuators. Its economics depend on volume, not price. Gross margin was only 6.8% in FY2023 and 8.5% in FY2025, which leaves little room after SG&A of KRW 29.5–33.3 bn [S1]. Since 2023, financial leverage rather than operations has driven the bottom line. Finance costs of KRW 10.2 bn in FY2025 were nearly double operating profit [S1]. The company is also a holding vehicle within the owner family's structure. It owns 100% of CTR EcoForging and 12.7% of sister company CTR Co., which has total assets of KRW 865.6 bn and net income of KRW 42.0 bn and attracted a KRW 70 bn pre-IPO private-equity investment in 2025 [S8], [S28].

Revenue$0.3B
Employees169
Market CapN/A
Founded1994
Ulsan, South Korea
CTK

CTK Co., Ltd

Premium
Information Technology

CTK is a Seoul-based "factory-free" cosmetics platform company. It designs, formulates, sources packaging for, outsources the manufacture of, quality-checks and ships finished colour-cosmetic and skincare products for third-party brands. Its customers are concentrated in North America and Europe. Historically CTK was an asset-light turnkey ODM intermediary. Sell-side research describes its client list as including global majors such as L'Oréal, Unilever and Estée Lauder, alongside indie brands. Since 2022 the company has repositioned around CTKCLIP, an online B2B "beauty creation" platform with low minimum order quantities aimed at indie brands. In 2025 it bought a US OTC/cosmetics manufacturing plant in Corona, California, which ended its purely factory-free model, and it added a biodegradable-plastics materials business in Canada. The result is a small-cap, export-oriented company (about 85% US and Europe revenue in 2024) in the middle of a capital-intensive transition. Revenue is recovering (+28.9% YoY in Q2 2026), but consolidated profitability is still negative on a trailing basis. --- ### What the company does In its own descriptions (2018 IR deck, recruitment materials, interviews), CTK presents itself as a full-service beauty provider. It covers trend research and content planning, product design, formula development, packaging engineering, marketing support, contract production, inspection and logistics, and delivers the whole package to brand owners on a turnkey basis. A long-standing differentiator in company materials is that CTK historically owned no cosmetics factory. It used selected external manufacturing capacity while keeping formulation know-how, packaging design and project management in-house. Sell-side coverage (Yuanta, February 2024) describes the model the same way: the company outsources production of finished cosmetics, exports most of it to global brands, and builds its value on planning, branding, marketing and R&D rather than on owned plants. The company's 2024 IR book lists its principal business lines as cosmetics and cosmetic containers (packaging). DART-based summaries describe CTK as making and selling cosmetics and cosmetic containers mainly for the US, UK and EU markets, and as running CTKCLIP, a platform that provides beauty-related services (Investing.com, from company filings). ### Business model and revenue model | Revenue stream | Nature | Disclosure status | |---|---|---| | Turnkey finished cosmetics (ODM/OEM via outsourced production) | Product sales. CTK invoices finished goods, mostly in USD | Main revenue driver. Sits within the CTKCLIP Division segment (about 94% of Q2 2026 revenue, DART via Butler.works) | | Cosmetic packaging/containers | Product sales of primary packaging designed by CTK | Included in the core segment. Separate split n/d | | Re-orders from existing customers | Recurring product revenue. Product life cycles at global clients typically run 3–5+ years | Re-order share above 70% (Hana, Dec 2024). Expected to rise from 70% to 74% in 2024 (Yuanta, Feb 2024) | | CTKCLIP platform (low-MOQ development for indie brands) | Product sales originated through the platform. No subscription model disclosed | Platform revenue share n/d | | US OTC/cosmetics contract manufacturing (CTK OTC Laboratories / "COL") | Contract manufacturing service and product sales. Consolidated from 2025 | Company cited COL consolidation as a driver of Q2 2026 growth (Asia Economy, Aug 2026) | | US fulfillment / 3PL (CTK USA Fulfillment Center) | Logistics services | Company cited higher North American fulfillment volumes in Q2 2026 (Asia Economy, Aug 2026). Revenue n/d | | Biodegradable resins and finished eco-products (CTK Bio / CTK Bio Canada) | Materials and product sales | About 2% of Q2 2026 revenue (Butler.works, DART) | | Licensing / subscription | None disclosed | — | ### Value-chain position CTK sits upstream of brand owners. It acts as an integrator between brand marketing teams and the physical supply base: formula labs, filling plants, packaging moulders and decorators. In the North American value chain, CTK now runs a vertically linked chain from development (CTKCLIP) to manufacturing (CTK OTC Laboratories) to fulfillment (CTK USA Fulfillment Center). Its US manufacturing subsidiary describes this chain in its own directory listing (GCI Magazine). ### Customer types and end-markets **Global multinational beauty groups:** Hana Securities (Dec 2024) names L'Oréal, Unilever and Estée Lauder as major customers. **Retailer private label:** Yuanta (June 2024) reports 11 new SKUs ordered for a large US retailer's "pure beauty" private-label line. **Indie and celebrity brands:** Examples include Inn Beauty Project and SerumKind (Beauty Independent directory). KTB (2019) noted US celebrity brand launches. **Korean brands seeking US entry:** The 2024–2025 OTC strategy targets Korean brand owners and Korean ODM/OEM peers that need FDA-compliant OTC production in the US (company IR, Dec 2024; eToday, Mar 2025). **Non-beauty (CTK Bio):** Foodservice, packaging, public authorities and hemp-product distributors for compostable resins and finished goods. Named counterparties include the Charlotte Regional Visitors Authority, Everyday Hemp Company, NLC Energy, Star Group, a Sysco vendor registration and Blue Bottle Korea. End-markets served are colour cosmetics (sell-side notes stress CTK's strength in make-up versus Korean ODM peers), skincare, suncare/OTC drug-cosmetics (sunscreen, acne care, skin protectants, sanitisers), and compostable packaging and consumer goods. ### Independent characterisation CTK is best understood as a project-based, North America-centric cosmetics supply-chain integrator. The original model was asset-light, cash-generative and dividend-paying: FY2017 operating margin was 21.6% (ETF Shopping, DART). It then went through a prolonged margin collapse (FY2020–FY2022) and has since tried three reinventions at once: an online platform for indie brands, a US owned-plant OTC strategy, and a biodegradable-materials venture. Revenue has stabilised at KRW 84–89bn a year in FY2023–FY2025. This is well below the KRW 110–124bn reached in FY2017–FY2021, and operating profitability has not yet returned on an annual basis. The 2025 acquisition moved the company from net-cash, low-leverage to a balance sheet with liabilities of KRW 110.5bn (FY2025), compared with KRW 34.7bn a year earlier.

Revenue$0.1B
Employees129
Market CapN/A
Founded2001
Seoul, South Korea
Crucialtec

Crucialtec Co., Ltd.

Premium
Information Technology

Crucialtec is a Korean mobile input and biometric component company that rose to global prominence in 2009–2011 as the world's largest supplier of Optical TrackPads (OTPs), the finger-navigation module used in BlackBerry and other feature-rich handsets, before pivoting to capacitive fingerprint modules (Biometric TrackPads, BTPs) supplied to LG, Huawei, Oppo, Vivo, Xiaomi and later Samsung. At its peak (FY2013–FY2014) consolidated revenue exceeded KRW 415 bn and market capitalization reached the KRW 500 bn range. Commoditization of fingerprint modules, loss of Chinese customers after 2017, and failed diversification (in-display fingerprint, micro-LED processing, a respiratory therapy device, vacuum-steam transfer equipment) produced five straight years of operating losses, capital impairment, and KOSDAQ delisting in February 2024. Today it is a very small unlisted company (single-digit headcount, FY2023 revenue KRW 21.4 bn) whose website still describes mobile, display (mini/micro-LED) and automotive optical-biometric businesses. --- ### Company's own description The company's website (current version) presents three business areas. In Mobile, it states that it developed and supplied previously non-existent categories of mobile input devices, specifically the Optical TrackPad (OTP) and Biometric TrackPad (BTP), to global handset makers, and that it also developed a Mobile Flash Module (MFM) to improve smartphone camera image quality. In Display, it says it has applied optical know-how from OTP and MFM to front-end and back-end process technology for mini-LED and micro-LED displays, has completed a production line, and is cooperating with domestic and overseas display makers. In Automotive, it describes plans to use its optical display technology for digital instrument clusters and headlamps, and to apply fingerprint recognition to vehicle ignition and door access. In its last listed-company period, disclosures (as summarized by Asia Economy in August 2022) described the company as a mobile-phone parts business with three product groups: Biometric TrackPads (fingerprint sensor modules), Optical TrackPads, and MFM/PL lenses, with fingerprint modules accounting for the bulk of revenue. ### Independent characterization | Revenue type | Approximate share | Evidence | |---|---|---| | Hardware product sales (modules) | ~100% | All disclosed product lines are physical modules; no licensing revenue disclosed | | Services / subscription | Not publicly disclosed (immaterial) | None disclosed | | Licensing / IP | Not publicly disclosed | Patents held, but no licensing income disclosed | Crucialtec is best characterized as a component module integrator in the smartphone supply chain. Its core competence historically was not sensor silicon design (it relied on partners such as Fingerprint Cards and IDEX for sensor ICs in the early BTP era) but the combination of module packaging, optical/capacitive integration, matching algorithms and mobile firmware. The company itself claimed in 2017 that it was the only firm possessing all five technologies needed for on-display fingerprint authentication: sensor IC, chip packaging, module, algorithm and mobile firmware. **Business model:** Product sales of hardware modules on a B2B, design-win basis to handset OEMs (overwhelmingly), with limited software/algorithm content bundled into modules. No meaningful subscription or licensing revenue has been disclosed. **Revenue model mix (best available evidence):** **Value chain position:** Tier-1/Tier-2 component supplier between sensor IC vendors (upstream) and smartphone OEMs/EMS (downstream). In FY2023, the company's balance sheet carried only KRW 0.2 bn of property, plant and equipment, which indicates an asset-light, largely outsourced or downsized manufacturing footprint by that time. **Customer types:** Smartphone OEMs (BlackBerry/RIM, Samsung Electronics, LG Electronics, HTC, Sharp, Kyocera, Motorola, Pantech, ZTE, Huawei, Oppo, Vivo, Xiaomi), consumer electronics OEMs (HP, Acer for smart TV/camera devices, per historical company descriptions), and a US healthcare product company (Proxy, fingerprint packaging supply announced April 2021). **End-markets served:** Smartphones (core), IoT and smart devices, displays (mini/micro-LED process—pre-commercial), automotive (development stage), healthcare devices (development stage, AIRoma).

Revenue$0.0B
Employees8
Market CapN/A
Founded2001
Yongin, South Korea
Crookes

Crookes Brothers Limited

Premium
Information Technology

Crookes Brothers Limited is a Durban-based agribusiness and land-development platform. The company was incorporated in 1913, with family roots going back to 1860, and has been listed on the JSE since 1948. It grows irrigated sugar cane and bananas across South Africa (Mpumalanga and KwaZulu-Natal), Eswatini and Zambia, and it monetises a legacy coastal land bank at Renishaw, near Scottburgh. In FY2026, sugar cane generated about two-thirds of revenue and bananas almost a quarter; property sales, tourism (Crocworld) and break crops made up the balance. In FY2026 the group took a R258.8m impairment, and in September 2026 it agreed to transfer its Mozambican macadamia business to its lender, AgDevCo, for US$2. It is therefore narrowing into a two-crop, Southern-Africa-centric operator built on community joint-venture farming models and a long-dated property pipeline. Silverlands (SA) Plantations holds 44.8% of the shares. CKS is small, thinly traded, asset-heavy, and trades well below book value. --- ### What the company does Crookes Brothers is a primary agricultural producer. It grows, harvests and sells unprocessed crops and does not mill sugar. The company also runs a property development arm that converts surplus coastal farmland into serviced land parcels and residential estates. Its operating model has four elements: 1. **Sugar cane growing.** Cane is grown on owned, long-leased and community-owned land in Mpumalanga (Komatipoort and Malelane), KwaZulu-Natal (Scottburgh), Eswatini (Big Bend) and Zambia (Mazabuka). It is delivered to third-party mills and paid for under industry pricing formulas: the Recoverable Value (RV) price in South Africa, the sucrose price in Eswatini and the ERC price in Zambia [S1]. 2. **Banana growing.** Bananas are grown in Mpumalanga (Mawecro) and Eswatini. Equity-accounted interests include Quinta Da Bela Vista (QBV, Mozambique, 49.8% joint venture) and Lebombo Growers (32.16% associate, the marketing agent). All South African and Mozambican fruit is sold through the Lebombo system, while Crookes markets the smaller Eswatini crop directly [S8]. 3. **Macadamias.** Murrimo Macadamia Limitada (MML) in Gurúè, Mozambique, sells nut-in-shell into export markets. The business is being exited: the Board stopped funding it from 1 January 2026, and a disposal to AgDevCo was signed on 18 September 2026 [S2]. 4. **Property.** Renishaw Property Developments (RPD/"Renprop", 85% held) develops the Renishaw Coastal Precinct and the Renishaw Hills residential estate near Scottburgh, KwaZulu-Natal, and earns land-sale, unit-sale and rental income [S8]. Smaller activities include the Crocworld Conservation Centre (tourism) and break-crop sales such as beans at Mawecro [S1]. ### Business and revenue model | Revenue stream (FY2026) | ZAR m | % of group | Pricing basis | |---|---|---|---| | Sugar cane | 522.0 | 67.1 | Industry formula prices (RV / sucrose / ERC), linked to world sugar prices, exchange rates and domestic protection [S1] | | Bananas | 179.4 | 23.1 | Market prices (municipal fresh produce markets and retail via Lebombo; direct sales from Eswatini) [S1][S8] | | Macadamias | 20.2 | 2.6 | US$ export nut-in-shell prices (forecast ~US$2.71/kg for the 2026 crop) [S1] | | Property | 28.9 | 3.7 | Unit sales, land sales, rentals [S1] | | Other | 27.1 | 3.5 | Tourism, break crops [S1] | | Total | 777.6 | 100.0 | — | Revenue is product-based and commodity-priced. There are no subscription or licensing revenues. Percentages derived from FY2026 segment revenue [S1]. **Value chain position.** Crookes sits at the upstream, primary-production end of the value chain. Its downstream exposure comes through its 32.16% stake in Lebombo Growers. According to the FY2025 IR, Lebombo and its subsidiary Lebombo Cape Properties have invested in blueberries, fruit processing and own-brand and private-label products for South African retailers [S8]. **Customers and end markets.** - Sugar mills in South Africa, Eswatini and Zambia buy the cane. End demand is domestic consumption plus export sugar; the FY2025 IR expects about 30% of South African sugar production to be exported over the long term. - Banana demand is mainly domestic South African fresh produce, sold through municipal markets and retail. - Macadamias were 100% exported through processor partnerships. - Property buyers are residential purchasers, healthcare, education, retail and fuel operators, and developers on the KwaZulu-Natal South Coast [S8]. **Currency mix.** The FY2025 IR estimates that roughly 22% of revenue is derived directly or indirectly from hard-currency markets over the long term, while production costs are mostly incurred in local currencies [S8]. ### The company's own description The FY2025 Integrated Report describes Crookes Brothers as a long-established agricultural business that has diversified beyond farming into property development to support sustainable agribusiness. It frames its vision around the line "We grow people. Our people grow food." [S8] The aspiration is to lead in sustainable agriculture while delivering consistent investor returns and transformational impact. The report presents the company as an "agricultural management platform." A multi-skilled central head office supports owner-driven estate teams, and new farms can be bolted on without large additional management cost [S8]. ### Independent characterisation In substance, CKS is a mid-sized, irrigated sugar-cane grower with a profitable banana business and a property business. The property arm can be meaningful in a given year but is lumpy. Its record shows repeated value destruction in higher-risk diversification bets: - Deciduous fruit was exited in FY2024 after years of underperformance. - Macadamias are being exited in FY2027 after cumulative impairments of R326.7m. The core sugar and banana operations together generated R185.9m of operating profit before biological-asset movements in FY2026 (R147.1m + R38.8m; derived [S1]). The binding constraints on value creation are: - sugar price policy in South Africa and Eswatini; - weather events; - head-office and finance costs on a small revenue base; - a controlling shareholder structure that keeps the free float small.

RevenueN/A
Employees2,009
Market CapN/A
Founded1860
Durban, South Africa
CR

CR Holdings Co., Ltd.

Premium
Information Technology

CR Holdings is the pure holding company at the top of the Chosun Refractories group (the "CR Group"), Korea's largest refractories maker. It was created in July 2023 when the 76-year-old Chosun Refractories split itself in two: the listed survivor became the holding company and the refractories business was spun off as a new listed company. CR Holdings owns 59.03% of that operating company. It also controls sintered-metal auto-parts makers (Daehan Sintered Metal, Samhan), a golf course (Hwasun Country Club), a real-estate development vehicle (CRI), overseas refractory joint ventures in China and Indonesia, and a portfolio of minority equity investments. Its consolidated revenue is about KRW 828 bn (FY2025). About three-quarters comes from refractories, much of it sold to POSCO. The rest comes mainly from automotive powder-metallurgy parts. The founding Lee family and related parties control 71.3% of the shares. The stock trades at roughly one-third of book value with a dividend yield of about 8–9%. The company reported a consolidated net loss in FY2025. --- ### What the company does CR Holdings is a holding company and has almost no operations of its own. Its standalone revenue in FY2025 was about KRW 18.7 bn (Catch/Incruit, citing DART FY2025). According to the business report summarised by WISEreport, that revenue comes from brand royalties (trademark fees), dividends from subsidiaries, and management advisory and consulting fees. In its own description, the company acts as the group's "strategic control tower": the spun-off operating company pursues growth in refractories, and the holding company coordinates the group and looks for new businesses. On a consolidated basis, the group runs four reportable activities through its subsidiaries (FY2025 business report, as summarised by WISEreport/FnGuide): 1. **Refractories manufacturing.** Run mainly through Chosun Refractories Co., Ltd. (462520), plus overseas units in China (Anshan, Qingdao) and Indonesia, and CR Innotech. Refractories are heat-resistant non-metallic materials that line furnaces and vessels. The products include shaped refractories (bricks), monolithic (unshaped) refractories, functional refractories for continuous casting (slide-gate systems, nozzles, stoppers), and refractory engineering and installation services. Main customers are steel mills, along with cement, glass, non-ferrous and petrochemical producers. 2. **Machinery parts manufacturing.** Run through Daehan Sintered Metal (51%), Samhan, and a Chinese powder-metallurgy joint venture in Yantai. Products are iron- and bronze-based sintered machine parts, mainly automotive sprockets, oil-pump gears and related powertrain parts, plus appliance parts such as connecting rods. 3. **Golf course operation.** Hwasun Country Club (50%, consolidated). 4. **Real estate.** CRI Co., Ltd. (100%), which holds real estate and an office development project in central Seoul through a project financing vehicle (Insadong PFV), plus leasing activity. ### Business and revenue model | Revenue type (consolidated) | Description | Approx. share | |---|---|---| | Product sales — refractories | Shaped, monolithic and functional refractories, with installation and engineering | ~74% of pre-elimination revenue (FY2024) | | Product sales — sintered machine parts | Auto parts (sprockets, oil-pump gears), appliance parts | ~29% of pre-elimination revenue (FY2024) | | Services — golf course | Green fees and operations at Hwasun CC | ~1.4% (FY2024) | | Real estate | Leasing and development | ~2.8% (FY2024) | | Holding-company income (standalone) | Royalties, dividends, consulting fees | eliminated on consolidation | Almost all consolidated revenue comes from selling products. Refractories are sold mostly under annual "BPA" (blanket purchase agreement) supply contracts with POSCO, covering both the Pohang and Gwangyang steelworks. Several of these contracts are "responsibility management" (책임관리) contracts. Under these, the supplier takes on performance responsibility for refractory linings in particular vessels (for example blast-furnace tap holes, ladles and runners). Pricing then partly reflects service and consumption performance, not just tonnage. The machinery-parts segment is a classic tier-2/tier-3 automotive supply business. In FY2023, sprockets and other auto parts made in-house were 24.7% of consolidated revenue, and traded auto parts (oil-pump gears and similar) another 2.9% (FY2023 business report, KIND). The golf and real-estate businesses earn fees and rent. *Segment percentages are reported before inter-segment eliminations, so they add up to more than 100% (FnGuide, FY2022–FY2024 business reports).* ### Value-chain position The group sits in the middle of the steel value chain. It buys refractory raw materials such as sintered/fused alumina, spinel, magnesia, silicon carbide and carbon. Historically some of these came from former affiliate Daehan Ceramics, which was the first Korean producer of sintered alumina and spinel. The group turns these into engineered linings and consumable flow-control parts, which it supplies and often installs at the customer's plant. Refractories are a consumable: a typical integrated steel mill uses them continuously, and how much it uses depends on crude-steel output and operating intensity. In the auto-parts business, the group powder-presses and sinters alloy powders (largely imported, e.g. from Australia) into finished parts for Korean OEMs and tier-1 suppliers. ### Customers and end markets **Steel (dominant):** POSCO is the anchor customer. The September 2025 contract package alone (four contracts, KRW 195.9 bn in total) was equal to about 39% of the operating subsidiary's FY2024 revenue. Hyundai Steel is also cited as a customer (Namdo Ilbo, October 2025). **Cement, glass, non-ferrous metals, petrochemical furnaces:** Smaller users of shaped and monolithic refractories and of furnace design and construction. **Automotive:** Hyundai Motor and Kia are named as customers in the company overview reproduced by Alphasquare. **Leisure / real estate:** Golf customers in South Jeolla; tenants and future users of the Seoul office project. ### Company's own description vs independent characterisation **Company description (paraphrased from the CEO greeting on crholdings.co.kr and the business report summary).** Chosun Refractories led Korea's refractories industry from its founding in 1947 and moved to a holding-company structure effective 10 November 2023. The stated aims were to strengthen each affiliate's independence and expertise, spread management risk, speed up decision-making, maximise group synergies and raise global competitiveness. **Independent characterisation.** In economic terms, CR Holdings is a family-controlled, mid-cap industrial conglomerate. About three-quarters of its earnings power depends on one domestic customer (POSCO) and on Korean steel volumes. Around that core sit a second, lower-growth industrial business (powder-metallurgy auto parts) and a set of non-core assets: a golf course, Seoul real estate and minority investments. The July 2023 spin-off, tender offer and in-kind share swap mainly strengthened the controlling family's indirect control, using treasury shares and the holding-company swap mechanism. Little operational change followed. Consolidated operating margins are thin (2–5% over FY2021–FY2025). Results below operating profit have been volatile because of financial costs and investment losses, and there were net losses in FY2025 and in Q2 2026. The market values the company at a deep discount to book value (P/B ≈ 0.32–0.36). That discount reflects the holding-company structure, low returns, related-party and governance concerns, and very little free float.

Revenue$0.6B
Employees35
Market CapN/A
Founded1947
Gwangyang, South Korea
CQV

CQV Co., Ltd.

Premium
Information Technology

CQV is Korea's leading — and, by its own recruitment description, the country's only domestic — manufacturer of pearlescent (pearl-luster) effect pigments, producing titanium-dioxide and iron-oxide coated platelets on five substrate families: natural mica, synthetic mica, glass flake, platy alumina and aluminium. It sells into three end-markets — automotive coatings, colour cosmetics/personal care and general industrial applications (paints, plastics, inks, synthetic leather, ceramics, security inks) — with roughly 70% of revenue exported through a network of about 100 distributors. CQV's technical differentiation rests on its platy alpha-alumina substrate (which the company describes as the world's second commercialised alumina pearl, developed in 2014) and on a high-mix, small-lot "smart factory". Since August 2023 it has been a non-wholly-owned subsidiary of China's GNMI, which in July 2025 also acquired Merck KGaA's Surface Solutions business (now SUSONITY), placing CQV inside one of the world's largest effect-pigment groups as its Korean, specialty-focused brand. --- ### Company's own description In its statutory filings CQV describes itself as being engaged principally in the manufacture and sale of pearl pigments and mica products, with its seat in Jincheon-gun, Chungcheongbuk-do (FY2025 audit report, note on general information). In investor materials, it classifies its principal business as the manufacture of metal oxides for inorganic pigments and related products, and frames its strengths around a global distributor network, breadth of application, an "unlimited" derivative product range built from five base substrates and multiple coating methods, and relatively limited sensitivity to any single industry cycle (CQV IR deck, May 2025). ### Independent characterisation CQV is a small-cap, niche specialty-chemicals company that converts mineral or synthetic platelet substrates into optically engineered effect pigments by wet-chemical deposition of metal-oxide layers (TiO2, Fe2O3 and others), followed by calcination, classification and surface treatment. Value creation comes from (a) substrate control — CQV manufactures its own substrate for selected lines (e.g., the Mirinae and Featheleve cosmetic ranges, per a 2024 interview with Summit Cosmetics Europe), and (b) coating know-how that determines colour, sparkle, hiding and durability. The business is formulation- and specification-driven: once a pigment is "specced-in" to an automotive OEM paint line or a cosmetic formula, switching costs are high because requalification (weathering tests of five years or more in automotive, per CQV IR) is slow and costly. ### Business and revenue model | Revenue type | FY2024 (KRW bn) | FY2025 (KRW bn) | FY2025 share | Comment | |---|---|---|---|---| | Product sales (own-manufactured pigments) | 55.03 | 51.96 | 91.9% | Core pearl pigments, Al-paste, coloured aluminium | | Merchandise sales (traded goods) | 4.73 | 4.16 | 7.4% | Resold goods; historically includes products sourced for customers' safety stock | | Services and other | 0.38 | 0.40 | 0.7% | Recognised over time | | Total | 60.15 | 56.52 | 100% | — | Source: FY2025 audit report (revenue note). Revenue is almost entirely product-based and recognised at a point in time (KRW 56.12 bn of KRW 56.52 bn in FY2025). There is no subscription or licensing revenue of significance. ### Value-chain position **Upstream inputs:** natural mica, synthetic mica (fluorphlogopite), glass flake, alumina precursors, aluminium flake, titanium tetrachloride (TiCl4) and iron salts, plus energy for calcination. From Q2 2025, CQV began sourcing synthetic mica and TiCl4 from its parent GNMI after completing permits (CQV IR, May 2025). **Midstream (CQV's position):** substrate preparation (alumina, selected cosmetic substrates), metal-oxide coating, calcination, surface treatment and quality release. **Downstream customers:** global and Korean paint/coatings formulators (who supply automotive OEMs), cosmetics brand owners and their OEM/ODM contract manufacturers, plastics compounders, ink makers, synthetic-leather and decorative-material producers. ### End-markets served | End-market | Share of revenue (Q2 2026) | Typical applications (per CQV IR) | |---|---|---| | Automotive | 45% | OEM and refinish paints via domestic and overseas paint companies; exterior building cladding | | Cosmetics | 35% | Eyeshadow, mascara, lipstick, BB cream, blusher; skincare (lotion, sunscreen, masks); personal care (shampoo, toothpaste, soap) | | Industrial | 20% | Paints, artificial marble, synthetic leather, specialty paper, appliances, ceramic coatings, tiles, in-mould film, security inks | | Aluminium paste etc. | ~1% | Metallic effect for injection moulding and coatings | Source: Butler.works segment split (Q2 2026 sales basis; components sum to ~101% due to rounding in the source). The automotive share has risen sharply over the decade as alumina-based automotive pigments scaled. ### Customer types CQV sells largely through distributors (around 100 worldwide) and directly to large coatings and cosmetics groups. The company has disclosed that cosmetic customers typically manufacture through global OEM/ODM contract producers, which it argues gives flexibility against tariff changes (CQV IR, May 2025). Historically, Sun Chemical was a key distributor/customer (distributor agreement from 2004), and in 2018 CQV reported a deliberate dealer-diversification policy that reduced the share of one large customer ("Company S") (CQV IR, Q3 2018).

Revenue$0.0B
Employees190
Market CapN/A
Founded2000
Jincheon-gun, South Korea
COWINTECH

COWINTECH Co. Ltd.

Premium
Information Technology

Cowin Robotics is a Korean industrial-automation group in the middle of a deliberate pivot. It began as a logistics-automation integrator for secondary-battery factories and is repositioning as a full-stack mobile-robot and "physical AI" platform company. Founded in 1998 and listed on KOSDAQ in 2019, it built its reputation by automating battery cell plants end to end, supplying stacker cranes, AS/RS, conveyors, lifters and transfer AGVs to Korean cell makers and their US and European joint ventures. Since 2025 it has mass-produced its own AMRs and has added industrial articulated robots, ESS assembly robots, overhead mobile shuttles (OHMS) and its own control software (RCS). It is also targeting ESS, semiconductor, automotive and general-logistics customers. In H1 2026, robots accounted for about 52% of standalone revenue. The group also consolidates Top Material, a battery system-engineering and LFP-cathode affiliate whose losses and receivables write-downs currently drive consolidated results. --- ### What the Company does Cowin designs, manufactures, installs and maintains automation systems for manufacturing plants: robots, material-handling equipment and the software that coordinates them. Under the FY2026 half-year report, it operates four business lines (KIRS, Sep 2026, citing DART): 1. **Robot automation (로봇 자동화)**, 82.0% of H1 2026 consolidated revenue. This covers *robots* (AMRs, articulated industrial robots and assembly robots), at KRW 41.8 bn or 51.9% of the line, and *automation systems* (AS/RS automated warehouses, racks, conveyors, lifters, shuttles and OHMS), at KRW 38.7 bn or 48.1%. 2. **Robot automation maintenance (로봇 자동화 유지보수)**, KRW 2.9 bn or 3.0% of H1 2026 revenue. This covers maintenance and refurbishment services on installed robots and equipment. 3. **Secondary-battery materials and engineering (2차전지 소재 및 엔지니어링)**, 13.3% of H1 2026 revenue, carried out through subsidiary Top Material. This covers battery system engineering for pilot lines and gigafactories (KRW 9.4 bn), battery materials (electrodes and LFP cathode, KRW 3.1 bn), merchandise (KRW 0.4 bn) and other (KRW 0.1 bn). 4. **Other**: solar machinery and parts sales of KRW 1.8 bn, or 1.8%. Under K-IFRS operating-segment reporting, the Company reports two segments. One is logistics automation systems (물류자동화 시스템), essentially the parent company and its overseas subsidiaries. The other is secondary-battery engineering (2차전지 엔지니어링), which is Top Material (KIRS, H1 2026). ### The Company's own description In its 2025–2026 investor materials and press releases, the Company has described itself in three successive ways. In 2024–2025 it was a "smart-factory total solution company" (IR decks, Apr and Sep–Oct 2025). From March 2026 it was a "smart automation and robotics company" (value-up plan). From August–September 2026 it has called itself an "intelligent robot integrated platform company". Its full-stack claim is that it builds robot hardware in house (modules, bodies, controllers, sensors) as well as the perception, decision, navigation and control software, central fleet management (RCS), and on-site system integration (Robot Newspaper, 13 Aug 2026; Newspim, 1 Sep 2026). Management states that the robot business grew at a 42.2% CAGR from 2020 to 2025 (Robot Newspaper, 1 Sep 2026). ### Business and revenue model | Dimension | Characterisation (analyst assessment based on disclosures) | |---|---| | Revenue model | Overwhelmingly project-based product sales. Contracts are recognised over time by percentage of completion (Eugene conference-call notes, Sep 2022). Services (maintenance) are about 3% of revenue. There is no subscription or licensing revenue disclosed. Software (RCS, simulation) is bundled into system contracts. | | Order structure | Single-supply contracts, often several purchase orders per customer site, typically 6–24 months in duration. Many counterparties are not disclosed for confidentiality reasons (multiple KRX disclosures). | | Sales channel | Direct sales only (KIRS, H1 2026). The Company also runs consortium or turnkey selling with Top Material and KGA. | | Value-chain position | Tier-1 equipment and integration supplier to cell makers, ESS integrators, automakers and semiconductor fabs. Upstream it buys steel structures, drives, sensors, PLCs and batteries; it took a 10.7% stake in robot-battery supplier Mobil Robotics in Aug 2026. Contract manufacturing of robots is being explored with Seojin System in Vietnam. | | Customer types | Large Korean conglomerates (Samsung, LG, SK and Hyundai are named as users of its robots; KIRS, Sep 2026). JV battery plants in North America and Europe (for example Ultium Cells, 2022). Global ESS manufacturers. Domestic semiconductor fabs. Start-up battery makers abroad, served through Top Material (for example Morrow, ONE and Prime Batteries). | | End-markets | Secondary batteries (EV and ESS cells), ESS module and pack assembly, automotive, semiconductors (wafer-test handling), chemicals and petrochemicals, food, solar | | Export dependence | 69% of revenue was exported (FY2025; KIRS). North America alone was 53% of H1 2026 revenue. | ### Independent characterisation Cowin is best understood as two businesses in one listed shell. The first is a cash-generative, mid-margin automation and mobile-robot integrator, the parent company. It returned to standalone profitability in 2025–2026: standalone operating profit was KRW 4.5 bn in 2Q25, KRW 1.6 bn in 1Q26 and KRW 2.5 bn in 2Q26. Its orders are diversifying away from EV cells towards ESS, automotive and semiconductor customers. The second is a loss-making, receivables-heavy battery engineering and materials subsidiary (Top Material). It caused a KRW 20.3 bn consolidated operating loss in 4Q25 through bad-debt provisions, and a segment loss of KRW 12.4 bn in H1 2026. The investment case therefore depends on (i) whether the robot pivot can scale margins at the parent, and (ii) whether Top Material's exposures (overseas receivables, an arbitration, and the ramp of the Pyeongtaek LFP cathode plant) stabilise.

Revenue$0.1B
Employees263
Market CapN/A
Founded1998
Asan, South Korea
Coupang

Coupang, Inc.

Premium
Information Technology

The 10-K FY2025 gives approximately 108,000, consistent with the figure above. A Wikipedia figure of approximately 95,000 for 2024 conflicts with the Korea CXO-derived figure; the discrepancy is likely a difference in measurement date or entity scope. A verified FY2023 headcount is not available in the sources reviewed. Roughly 20,000 contracted "Flex" couriers are not included in the direct headcount (Herald Corp, June 2026). Coupang is Korea's dominant e-commerce platform. It is a vertically integrated retailer-marketplace that owns its fulfillment centers, line-haul and last-mile delivery network. This allows it to offer next-day, dawn and same-day "Rocket" delivery across most of Korea, with order cut-offs as late as midnight. Its WOW paid membership bundles free fast delivery, free returns, Coupang Eats food-delivery discounts and Coupang Play streaming. Coupang generated $34.5B of FY2025 revenue (+14% reported, +18% FX-neutral). Over 90% of revenue is earned through Korean entities. The core Product Commerce segment is profitable (FY2025 segment adjusted EBITDA margin 8.4%). This funds roughly $1B a year of losses in Developing Offerings: Taiwan Rocket Delivery, Coupang Eats, Coupang Play, Rocket Now food delivery in Japan, and the Farfetch luxury marketplace. Since November 2025, the equity story has been dominated by an insider data breach affecting about 33.7M accounts. This led to a $1.2B voucher program, a record KRW 624.7B ($410M) privacy fine, and escalating Korean regulatory pressure that has become a U.S.–Korea trade issue. --- ### Company's own description (10-K FY2025, Item 1) Coupang describes itself as "a technology and Fortune 150 company listed on the New York Stock Exchange that provides retail, restaurant delivery, video streaming, and fintech services to customers under brands that include Coupang, Eats, Play, Rocket Now, and Farfetch." It states that it serves millions of customers in over 190 countries and territories. Its stated customer proposition rests on four elements: - fast, reliable delivery, ranging from next-day to dawn and same-day, with order cut-offs as late as midnight; - broad selection across essentials, general merchandise, fresh grocery, luxury and niche categories; - frictionless returns; - digital services such as streaming and payments. WOW membership adds further delivery benefits and perks. The company emphasizes "controlling the entire end-to-end experience — from technology and automation to fulfillment and logistics." On the merchant side, the 10-K highlights four points: - the role of small and medium-sized enterprises (SMEs), with more than 75% of Korean SME sellers based outside Seoul; - the Fulfillment and Logistics by Coupang (FLC) offering for third-party merchants; - private-label programs; - Rocket Overseas, a cross-border channel to Taiwan. It also cites advertising for suppliers and merchants, and Farfetch as a luxury marketplace connecting boutiques and brands with consumers. ### Business and revenue model | Revenue line | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |---|---|---|---|---|---| | Net retail sales (1P owned inventory) | 16488.0 | 18338.2 | 21223 | 23866 | 26312 | | Net other revenue (3P services, membership, ads, Eats, Play, other) | 1918.4 | 2244.4 | 3160 | 6402 | 8222 | | Total net revenues | 18406.4 | 20582.6 | 24383 | 30268 | 34534 | | Net other revenue share of total (%) | 10.4 | 10.9 | 13.0 | 21.2 | 23.8 | | Revenue line | FY2022 | FY2023 | FY2024 | |---|---|---|---| | Third-party merchant services | 1870 | 2576 | 5580 | | Other revenue | 375 | 584 | 822 | Coupang's revenue falls into two GAAP lines. The 10-K FY2024 disaggregation splits "net other revenue" further. **Revenue mix (USD M)** *Sources: FY2022 release (FY2021–22); FY2023 release; FY2025 release and 10-K FY2025 (FY2024–25).* **Detail of net other revenue (USD M)** Source: 10-K FY2024 XBRL disaggregation. **Independent characterization.** Coupang is best understood as a first-party (1P) inventory retailer. Roughly three-quarters of revenue is gross retail sales recognized at full selling price. This 1P core is increasingly layered with higher-margin service revenue streams: - 3P marketplace commissions; - FLC fulfillment fees, recorded net from Q2 2023, which depressed reported growth by about 5 points in FY2023; - WOW subscription fees; - retail-media advertising; - Eats commissions and delivery fees; - streaming; - fintech. The rising "net other revenue" share (10% in FY2021 to 24% in FY2025) is the main driver of gross margin expansion from 16.0% to 29.4% over the period. Part of the FY2024 step-up reflects the Farfetch marketplace, consolidated from February 2024. **Position in the value chain.** Coupang sits between suppliers/brands and end consumers. It performs: - sourcing (including direct sourcing of produce); - warehousing (over 78 million sq ft of owned or leased fulfillment and logistics space, per 10-K FY2025); - line-haul and last-mile delivery, using a largely directly-employed workforce plus contracted Flex couriers; - payments (Coupang Pay); - media (advertising, Play). **Customer types.** - Consumers: 24.7M Product Commerce active customers in Q2 2026. - 3P merchants and SMEs. - Brands and suppliers (1P vendors and advertisers). - Restaurants (Eats, Rocket Now). - Luxury boutiques and brands (Farfetch). - External GPU-cloud customers (Coupang Intelligent Cloud GPU-as-a-Service). **End-markets.** Korean retail (general merchandise, grocery/fresh, consumer electronics, beauty, apparel), Korean food delivery, Korean streaming, Korean payments, Taiwan e-commerce, Japanese food delivery, and global luxury e-commerce.

RevenueN/A
Employees108,131
Market CapN/A
Founded2010
Washington, US
Cosnine

Cosnine Co., Ltd.

Premium
Information Technology

| Item | Detail | Source | |---|---|---| | Legal name | 주식회사 코스나인 / Cosnine Co., Ltd. | Korean Wikipedia; KRX disclosures | | Former names | Chamtech (참테크) → Chamtech Global (참테크글로벌) → Crucial MS (크루셜엠스) → Samwoo MS (삼우엠스) → 9Complex (나인컴플렉스, from June 2019) → Cosnine (from 2020) | Korean Wikipedia; IB Tomato (2021); Saramin | | Founding | Incorporation date given as 20 June 2001. Some media say the company was founded in 2000 as a telecom-equipment maker. The sources conflict and both are noted. | Korean Wikipedia; Saramin; Bloter (23 Apr 2025); IB Tomato | | Founder | Lee Ki-hong (이기홍) | Korean Wikipedia | | Incorporation jurisdiction | Republic of Korea (주식회사) | — | | Headquarters address | 27 Hagunsandan 2-ro, Yangchon-eup, Gimpo-si, Gyeonggi-do, South Korea. The Gimpo land and buildings were sold in January 2025 (see Section 8). | Korean Wikipedia; Simply Wall St | | Exchange / ticker | KOSDAQ: 082660 (A082660). Listed 5 Oct 2005; delisted 21 Sep 2026. | Korean Wikipedia; KRX/DART 8 Sep 2026 | | ISIN | KRX standard construction gives KR7082660002, but this was not checked against a registry. | — | | CUSIP | Not applicable (no US listing) | — | | Fiscal year end | 31 December | KIND filings | | Employees | 69–75 per aggregators (mid/late 2024) | Simply Wall St; Google Finance | | Auditor (FY2025) | Daesung Accounting Corp. (대성회계법인). Opinion: disclaimer. | FY2025 annual report (KIND, 24 Mar 2026) | | Auditor (FY2024) | The company received a disclaimer of opinion on 21 Mar 2025. | Cosinkorea (11 Apr 2025) | | Interim reviewer (H1 FY2023) | Samdo Accounting Corp. (삼도회계법인). Review conclusion: unqualified. | Top Daily (16 Aug 2023) | | Market capitalisation | Last pre-suspension value KRW 47.83bn, at KRW 480/share × 99.64M shares (7 Aug 2024). There is no current market value since delisting. | Google Finance; Simply Wall St | | Shares outstanding | 99.64M (2024) | Google Finance; Simply Wall St | | Website | www.cosnine.com | — | | Corporate status flag | Startup database THE VC lists the company status as "closed" (폐업). This is not confirmed by a primary source. | thevc.kr | Cosnine Co., Ltd. is a former KOSDAQ-listed South Korean contract cosmetics manufacturer. It produced skincare and colour cosmetics on an OEM/ODM/OCM basis from a CGMP- and ISO 22716-certified plant in Gimpo, Gyeonggi-do. The plant included an underground production line, which was a first for the Korean industry. The listed shell traces back to Chamtech, a 2000s telecom-equipment and handset-case maker. It changed its name five times before absorbing the cosmetics maker Cosnine in December 2019 and adopting its name in 2020. Its best-known product heritage is the Gerissong horse-oil cream, reported at more than 30 million units sold. After 2020 the company never earned an operating profit. Revenue shrank from about KRW 21bn (FY2020) to about KRW 9.7bn (FY2024). Governance failures followed: control contests, alleged embezzlement of KRW 9.08bn by former management, consecutive audit disclaimers, an abandoned court rehabilitation, and finally delisting in September 2026. Today it is best characterised as a distressed, delisted entity with no demonstrated going-concern value. --- ### What the company does At its operating peak, Cosnine was a contract development and manufacturing organisation (CDMO) for cosmetics. It operated under three engagement models: **OEM:** manufacturing to the client's formula. **ODM:** Cosnine develops and manufactures the product. **OCM:** a broader service that includes concept and brand support. Aggregator business descriptions (Simply Wall St, citing S&P Global data) list two product families: **Basic skincare:** creams, serums, toners, essences, lotions, moisturisers, eye creams and sunscreens. **Make-up:** foundations, CC/BB creams, concealers, blushes, eyeshadows, eyeliners, mascaras, lipsticks and lip glosses. The company also stated: - It had obtained quasi-drug (의약외품) manufacturing and sales authorisation. - It held Halal certification. - It held patents related to horse-oil (마유) formulations (Etoday, 2019). Saramin's registry summary lists three registered activities: cosmetics manufacturing; metal can and other packaging-container manufacturing; and cosmetics and toiletries wholesale. ### Ancillary and attempted businesses | Business | Description | Period | Evidence | |---|---|---|---| | ITS / "Smart" business | Building and maintaining intelligent transport information systems | Legacy from earlier incarnations; still reported in 2020–2022 | Asia Economy (7 Oct 2020); Dealsite (20 Jul 2022) | | China cosmetics distribution | Distribution and sales via the Shanghai subsidiary (Cosnine Shanghai) | c.2020–2024 | Dealsite (20 Jul 2022; 24 Jul 2024) | | Lithium carbonate distribution and solar | Through subsidiary Green Energy Innovation, set up 21 Jul 2023. Letters of intent for lithium carbonate supply with Shandong Nanbeiji New Energy; supply talks with another Chinese group. | 2023 onward | Top Daily (16 Aug 2023) | | AI, hydrogen, hotel/tourism | Articles of incorporation amended for these new businesses after the July 2024 change of control | 2024 (aspirational) | Dealsite (24 Jul 2024) | | Mobile-phone cases (legacy) | Original handset-case manufacturing. The company exited because of poor results. | Pre-2019 | Asia Economy (7 Oct 2020); THE VC | ### Revenue model Revenue came mainly from product sales of contract-manufactured cosmetics, invoiced per unit or order to brand-owner clients. ITS maintenance contracts generated small service revenue. There was no subscription or licensing revenue of note. Cosmetics accounted for: **94%:** of revenue in H1 2020 (Asia Economy, 7 Oct 2020) **64.1%:** of revenue in 2019, the year of the Cosnine merger (IB Tomato) - about 95% of revenue in 2020 (IB Tomato) ### Value-chain position and customers Cosnine sat in the midstream manufacturing layer of the K-beauty value chain. Its position looked like this: **Upstream:** raw-material and packaging suppliers. **Its own layer:** formulation, filling and packaging. **Downstream:** brand owners, who sell through road-shops, duty-free, e-commerce and export channels. Cosnine itself sold into China through its Shanghai unit. Named counterparties in public sources: - Chinese conglomerate Bunma Group (contract-manufacturing and distribution cooperation, 2022). - Genomics company Clinomics (bio-based anti-ageing cosmetics MOU, 2023). The company's customer list, customer concentration, and end-market split were not publicly disclosed in the sources reviewed. ### Company self-description vs independent characterisation **Company's description.** In its last public positioning, Cosnine described itself as a CGMP- and ISO-based cosmetics manufacturer building out OEM, ODM and OCM capabilities (medigatenews, 27 Jun 2023). In 2023, management said it expected a revenue rebound from: - the end of Korea's indoor mask mandate, and - China's reopening. Management argued that simply returning to 2020 revenue would mean two to three times growth (Dealsite, 20 Jan 2023). **Independent characterisation.** The evidence points to a sub-scale, chronically loss-making contract manufacturer: **Negative gross margins:** FY2022 −24.75%, FY2023 −4.00%, FY2024 about −11.9%. **Little pricing power or utilisation:** much of the plant was reportedly idle during COVID-19 (Dealsite, 20 Jul 2022). **Diversification without results:** repeated moves into unrelated businesses (lithium, AI, hydrogen, hospitality) produced no disclosed revenue. **Fragile governance:** The FY2025 annual report contains a disclaimer of opinion. FY2025 operating revenue is therefore not reliably verifiable.

Revenue$0.0B
Employees69
Market CapN/A
Founded2001
Gimpo, South Korea
Cosmecca

Cosmecca Korea Co., Ltd.

Premium
Information Technology

Cosmecca Korea is the third-largest pure-play cosmetics ODM/OEM in Korea, behind Cosmax and Kolmar Korea. It brands its model as "OGM" (Original Global-standard Manufacturing). It formulates, develops, and manufactures skincare, functional/OTC, and colour cosmetics for third-party brands. It does not sell under its own consumer brands. Production runs through three entities: - The Korean parent, with plants in Eumseong and Cheongju and a new Ochang site under construction. - Majority-owned Englewood Lab, with plants in Totowa (New Jersey) and Incheon. - A small China subsidiary in Pinghu. The investment case rests on the global boom in Korean indie and "K-derma" brands, whose exports flow through Korean ODMs. From FY2023 to FY2025, consolidated revenue rose from KRW 470.7 bn to KRW 640.9 bn and operating margin from 10.4% to 13.0%. 1H 2026 revenue grew 46.8%. The company has a medium-term revenue target of KRW 1 trillion and a ~KRW 200 bn capacity build-out at Ochang. Its US manufacturing base gives it a hedge against tariffs. --- ### What the company does Cosmecca Korea is a business-to-business cosmetics manufacturer. Its services cover: - formulation research and development, - product proposal and concept development (ODM), - contract manufacturing to customer specification (OEM), - quality assurance and regulatory support, - packaging procurement under "turnkey" contracts. It serves brand owners: Korean indie brands, global prestige and mass beauty houses, and US indie and OTC brands. S&P's company description, carried on StockHub, lists its products as: - skincare (lotions/toners, creams, essences, cleansers, mask sheets, scalp, body and bath products), - functional products (whitening, anti-wrinkle, UV protection, acne care), - colour cosmetics (BB/CC creams, foundation, lipstick, mascara). ### Company self-description The company now calls itself a "global cosmetics OGM (Original Global-standard Manufacturing) specialist." Management uses the term to stress: - production to international regulatory standards (Korea MFDS, US FDA OTC monograph, Health Canada, Australia TGA, halal), - a Korea–US two-hub structure, - proprietary formulation development. The company credits its growth to the following (Cosmorning and CosinKorea, 2025–2026): - order wins from Korean and global indie brands, - new-format development (it claims it launched the world's first triple-function BB cream), - tailored proposals and fast response, - automation, including the "Cosmecca Production System (CPS)". ### Independent characterisation Economically, Cosmecca is a capacity-constrained, working-capital-intensive contract manufacturer whose volumes track its clients' sell-through. Key features: **Revenue model:** almost entirely product revenue (per-unit manufacturing). Small service income exists (Englewood Lab reports ~3% "services," Q2 2026). There is no subscription or licensing revenue. **Turnkey vs. non-turnkey mix:** this materially changes reported revenue but not necessarily margin. Under turnkey contracts Cosmecca buys the containers and passes their cost through in the price. Under non-turnkey ("용기 사급") contracts the client supplies packaging. A large Englewood Lab Korea client switched to non-turnkey in 2024, which depressed reported revenue (Yuanta, Jan 2025; Hana, Jul 2025). **Value-chain position:** midstream. Upstream are raw-material and packaging suppliers; supply disruptions hit 2Q26 China results and the 3Q26 Korean results (KB, Oct 2026). Downstream are brand owners and, beyond them, retailers and marketplaces such as Amazon, TikTok Shop, Olive Young, Ulta and Sephora. **Customer types:** - Korean indie/derma brands that export globally (the main growth driver since 2023). - Global multinationals (Estée Lauder was cited as a key US/EU client as early as FY2016; Hankyung, Feb 2017). - US indie and OTC sunscreen brands (Englewood Lab: >93% of revenue from US customers at end-2024; Dealsite, Aug 2025). - Chinese local and global brands (China subsidiary). **End-markets:** prestige and masstige skincare, dermocosmetics, sun care/OTC, base and colour make-up (cushions, BB), masks (hydrogel), and expanding into hair and body care. ### Customer concentration The company does not name its clients. Broker commentary tracks them by letter: - At 4Q25, client "D" grew 35% QoQ and became the largest customer (KB, Feb 2026). - In 2Q26, client "A" entered the top ten, and customers ranked 5th–10th grew from ~1% to 2–3% of revenue each (Hana, Aug 2026). - At Englewood Lab Korea, orders from customer "G" weakened in 2Q26, cutting that unit's profit 13% YoY (Hana, Aug 2026). These data show concentration is falling but still material.

Revenue$0.5B
Employees531
Market CapN/A
Founded1999
Eumseong-gun, South Korea
CosmaxNbt

Cosmax Nbt, Inc.

Premium
Information Technology

Cosmax NBT is the health functional food contract-development and manufacturing arm of the Cosmax Group, the world's largest cosmetics ODM. It formulates and manufactures tablets, hard and soft capsules, powders, liquids, stick jellies and gummies for brand owners, retailers, pharmaceutical and food companies, direct-selling networks and online sellers in Korea, China, the US, Australia and Southeast Asia. Its production network spans Korea (Icheon), Australia (Melbourne, TGA-certified) and, until a 2025–26 restructuring, the US (Texas). The company differentiates on formulation technology: the micro-sized tablet platform a:dam, the chewable a:dam-MINI, the melt-in-mouth BoRrr format, micro-emulsion gummies and a dedicated probiotic line. It also develops proprietary individually recognized functional ingredients such as Respecta. After four years of net losses driven by overseas start-up costs, NBT reached record quarterly revenue and operating profit in 1H FY2026. More than 70% of its sales are export-linked, which makes it a leveraged play on China, cross-border e-commerce and "K-wellness" demand. --- ### Company's own description In its corporate materials, Cosmax NBT describes itself as a health functional food company whose businesses are: (i) research and development of functional raw materials and ingredients; (ii) manufacturing of health functional foods and health-oriented foods; and (iii) distribution of health functional foods (Google Finance company description, sourced from company filings). Its stated vision is to become the "2030 Global No.1 health functional food company." It describes a "one-stop service" covering product proposals tailored to local markets, regulatory support in each country, and design and marketing support for clients. That service is built on what the company calls Korea's largest health functional food plant in Icheon, Gyeonggi-do, plus a US–Australia–China supply chain (company recruiting profile on Saramin). The business-purpose clause lists manufacturing, sale, import/export and mail-order sale of health functional foods and processed health beverages (JobKorea). ### Independent characterization NBT is a mid-sized, capital-intensive contract manufacturer in a fragmented Korean HFF ODM market. It has an unusually high dependence on export and China-linked demand. Its economic model has three layers: 1. **ODM (Original Design Manufacturing).** NBT develops the formulation and often the concept, then manufactures under the client's brand. This is the core revenue engine and earns higher gross margins than OEM because formulation IP and regulatory dossiers carry value. 2. **OEM.** NBT manufactures to the client's specification. The company has said the US subsidiary historically relied on OEM work, a structural reason for that unit's losses. 3. **OBM (Original Brand Manufacturing).** NBT supplies its own developed products and proprietary ingredients, which clients sell under their brands. Examples are individually recognized ingredients such as Respecta (women's vaginal-health probiotic) and the ashwagandha sleep ingredient, which carry pricing power and repeat-order characteristics. **Revenue model:** Almost entirely product sales. In Q2 FY2026, products (manufactured goods) were 91% of revenue, merchandise (traded goods) 8% and other 1% (Butler.works, citing the 2Q26 filing). There is no subscription or licensing revenue of note. Ingredient know-how is monetized through product pricing rather than royalties. **Value-chain position:** Midstream. NBT buys raw materials (vitamins, probiotics, botanical extracts, collagen, excipients and packaging), formulates, manufactures and packages finished dosage forms, and sells B2B. It does not own consumer brands at scale. **Customer types:** - Korean brand owners and retailers. New 2026 channels named by Yuanta include convenience stores, Olive Young and Daiso. - Chinese brand owners selling through direct-selling (door-to-door) and cross-border e-commerce ("direct-purchase", 직구) channels. - US online and retail brands. The US subsidiary has been converted into a sales office supplied from Korea. - Australian and Southeast Asian clients served from the Melbourne plant, including the halal-certified route into Indonesia. - Pharmaceutical and food companies, and network-marketing companies. **End-markets:** Korean HFF (estimated KRW 6.4 trillion in 2025), Chinese HFF and cross-border e-commerce, US dietary supplements, Australian complementary medicines, and emerging Indonesian (halal) and Indian demand. **Scale indicators:** 32 countries and 300+ clients (Korea IR Council, 2022); "180+ clients" (company recruiting profile, undated). The company received the US$70 million Export Tower at the 62nd Trade Day in December 2025, seven years after its US$50 million tower in 2018 (Kukinews, 8 Dec 2025).

Revenue$0.2B
Employees513
Market CapN/A
Founded2002
Seongnam, South Korea
CosmaxBTI

Cosmax BTI, Inc.

Premium
Information Technology

Cosmax BTI is the apex holding company of the Cosmax Group, the Korean-founded enterprise widely described as the world's largest cosmetics original design manufacturer (ODM). Its economic value rests on three layers. First, an equity-method stake of roughly 27% in Cosmax, Inc., the group's listed cosmetics ODM, which reported record FY2025 revenue of KRW 2,398.8 bn and operating profit of KRW 195.8 bn. Second, controlling stakes in a health-functional-food (HFF) ODM platform — KOSDAQ-listed Cosmax NBT (43.53%) and unlisted Cosmax Bio (68.37%) — plus a small pharmaceutical subsidiary, Cosmax Pharma (79.64%). Third, its own "separate" operations: global raw-material purchasing and export agency for group companies, shared-services fees, and dividend income. Consolidated FY2025 revenue was KRW 645.2 bn with operating profit of KRW 27.0 bn. The stock trades at a deep discount to the market value of its listed holdings, and family succession was formalised in May 2026. --- ### What the company does Cosmax BTI performs two functions simultaneously: 1. **Pure holding/control function.** It sets group vision and strategy, allocates capital, oversees human-resources and financing plans, and holds controlling or significant stakes in operating companies. The company's own description (group website) characterises BTI as the body that sets strategic goals and develops HR and financing plans for the whole Cosmax Group, while securing growth engines in health and functional foods, bio-capsules and new businesses beyond the cosmetics core. 2. **Operating ("business holding") function.** The parent entity itself books revenue from (a) sales of goods and merchandise — principally global raw-material procurement and export agency services for subsidiaries and the Cosmax, Inc. associate; (b) shared-services-center (SSC) fees and service revenue; and (c) dividend income from affiliates. Per a valuation-platform summary of the FY2025 annual report, BTI had 14 consolidated subsidiaries as of June 2025 and performs global raw-material purchasing and export agency for subsidiaries. ### Reporting segments (as presented in company IR materials) | Segment | Entity | Ownership by BTI | Accounting | Business | |---|---|---|---|---| | Health functional food (NBT) | Cosmax NBT, Inc. (KOSDAQ: 222040) | 43.53% direct (43.93% incl. related parties), FY2025 annual report | Consolidated | HFF ODM/OBM with Korea–Australia–China–US value chain | | Health functional food (BIO) | Cosmax Bio, Inc. (unlisted) | 68.37% (FY2025 annual report) | Consolidated | HFF ODM — tablets, softgels, liquids, jellies, powders | | Pharma | Cosmax Pharma, Inc. (unlisted) | 79.64% (FY2025 annual report) | Consolidated | Pharmaceutical intermediates and finished drugs (CMO-type) | | Holding (BTI separate) | Cosmax BTI parent | n/a | Parent | Raw-material sourcing/export agency, SSC fees, dividends | | Cosmetics ODM (associate) | Cosmax, Inc. (KOSPI: 192820) | 27.23% direct; 27.51% incl. related parties (FY2025 annual report) | Equity method | World's largest cosmetics ODM | ### Revenue model **Product (ODM/OEM manufacturing):** the overwhelming majority of consolidated revenue — contract development and manufacturing of HFF and pharmaceuticals for brand owners (NBT, Bio, Pharma). **Trading/merchandise:** BTI-separate procurement and resale of raw materials/merchandise to affiliates. **Services/fees:** SSC and management-service fees. **Investment income:** dividends (booked as revenue in BTI-separate; e.g., KRW 10.1 bn of FY2025 dividends recognised in Q1 2026) and equity-method income from Cosmax, Inc. (non-operating, below operating profit). **Subscription/licensing:** not material / not disclosed. Revenue mix by business (Q2 2026, per Butler/DART summary): health functional foods 64%, other (holding/trading) 32%, pharma 4%. ### Value-chain position, customers and end-markets The group sits in the B2B "invisible" middle of the beauty and wellness value chain — between ingredient suppliers and consumer brands. Customers are brand owners: global multinationals (Fortune's 2026 profile cites Shiseido, Yves Saint Laurent and Lancôme among Cosmax's roughly 4,500–5,000 customers), Korean "indie" K-beauty brands, Chinese domestic brands (e.g., Yatsen via JV), and, in HFF, network-marketing (MLM) companies, large retailers, home shopping, online channels, and pharma companies. End-markets: skincare, color cosmetics, suncare, hair/body (via Cosmax, Inc.); dietary supplements/HFF (vitamins, probiotics, collagen, individually-recognised functional ingredients); and generic/OTC pharmaceutical products (Cosmax Pharma). ### Independent characterisation Economically, Cosmax BTI is best understood as a leveraged, owner-controlled holding vehicle whose net asset value is dominated by its Cosmax, Inc. stake, wrapped around a sub-scale and historically loss-making HFF manufacturing platform. Consolidated earnings understate BTI's look-through earnings power because Cosmax, Inc.'s profits arrive only as equity-method income and dividends. The investment case therefore hinges on (i) Cosmax, Inc.'s K-beauty-driven growth, (ii) whether the HFF turnaround visible in H1 2026 is durable, and (iii) whether governance and capital-allocation changes narrow the holding-company discount.

Revenue$0.5B
Employees341
Market CapN/A
Founded1992
Seongnam, South Korea
CORESTEMCHEMON

CORESTEMCHEMON Inc.

Premium
Information Technology

CorestemChemon is a small-cap Korean biotechnology company that combines two businesses with very different economics under one listed shell. The first is a cell-therapy franchise built around Neuronata-R (lenzumestrocel), an autologous bone-marrow-derived mesenchymal stem cell (MSC) therapy for amyotrophic lateral sclerosis (ALS) that has been sold in Korea since 2015 under a 2014 conditional approval. The second is a non-clinical contract research organisation (CRO), inherited from Chemon, which provides toxicology, pharmacokinetics, safety pharmacology and environmental toxicity testing and generates essentially all current revenue. The company's Phase 3 ALSummit trial missed its primary endpoint in the overall population but showed benefit in slow-progressing patients; Korea's MFDS approved a label modification in May 2026, keeping the product on the market. The investment case now hinges on restarting manufacturing, an FDA Type C meeting and a targeted 2027 US BLA filing, all funded from a thin balance sheet. --- ### Company's own description In company materials, CorestemChemon describes itself as a "total health care" company with a full drug-development cycle capability — from early non-clinical experiments through Phase 1–3 clinical development — combining a cell-therapy developer/manufacturer with Korea's first private non-clinical CRO [S25][S26]. Its corporate profile describes the biopharmaceuticals division as focused on rare and intractable diseases (ALS, lupus, neuromyelitis optica, multiple system atrophy) and the non-clinical CRO division as offering toxicity studies, pharmacokinetic analysis, safety pharmacology and environmental toxicity testing [S38]. ### Independent characterisation In practice, CorestemChemon is a service business funding a single-asset biotech. The CRO division provides recurring (though cyclical) fee-for-service revenue; the biopharmaceutical division has contributed only low single-digit percentages of revenue even when Neuronata-R was in production — 4.41% of revenue (KRW 1.3 bn) in the first nine months of 2023 and KRW 0.6 bn of KRW 15.5 bn in H1 2024 [S31][S30]. Since Q1 2025, Neuronata-R manufacturing has been suspended pending a new manufacturing site certification and the MFDS license modification, so Q2 2026 revenue was 100% non-clinical CRO services [S9][S1]. ### Revenue model mix | Revenue stream | Model | Weight (latest disclosed) | Notes | |---|---|---|---| | Non-clinical CRO services | Project-based contract research; revenue recognised by percentage of completion | ~100% of Q2 2026 revenue | Contract backlog in progress at 30 Jun 2026: KRW 27.15 bn total, of which KRW 14.46 bn already recognised [S8] | | Neuronata-R (product sales) | Per-patient autologous manufacturing and supply to hospitals | ~0% since Q1 2025 (production halted) | Historically ~4% of revenue [S30][S31] | | Licensing / royalties | None disclosed | 0% | No out-licensing revenue disclosed | | Subscription | None | 0% | — | ### Value-chain position **Cell therapy:** vertically integrated — R&D, clinical development, GMP manufacturing (Yongin plant; new Osong plant), and supply. Because the product is autologous, each dose begins with a bone-marrow harvest from the patient, followed by cell culture and intrathecal injection; the product's expiry is 48 hours after manufacture [S42]. **CRO:** upstream service provider to pharmaceutical, biotech, health-functional-food and cosmetics-ingredient developers, and to government-funded research projects [S8][S9]. ### Customer types and end-markets | Business | Customer types | End-markets | |---|---|---| | Neuronata-R | ALS patients treated through Korean hospitals; prospectively foreign patients travelling to Korea from 2027 [S17] | Rare neurodegenerative disease (ALS/MND) | | Non-clinical CRO | Korean pharma/biotech sponsors; national R&D projects; functional food and cosmetics-material developers [S8][S9] | Drug development outsourcing (preclinical) |

Revenue$0.0B
Employees391
Market CapN/A
Founded2003
Seongnam, South Korea
Corentec

Corentec Co., Ltd.

Premium
Information Technology

Corentec is Korea's first dedicated manufacturer of artificial joints and its domestic share leader in total hip arthroplasty. Its core portfolio is primary and revision hip and knee replacement systems: BENCOX/BENFIX hips, and LOSPA and EXULT knees. Shoulder (CORALIS), spinal fixation (LOSPA IS), sports-medicine and trauma lines complement them. The company differentiates on proprietary implant surface technologies, MAO (micro-arc oxidation) and DMT coatings. It combines a cost-competitive Korean manufacturing base with regulatory clearances in the US (FDA), Japan (MHLW), India (CDSCO), Mexico, Brazil and about 20 export markets. The group also holds a 51.2% stake in Sun Healthcare International. That subsidiary owns a US ambulatory surgery centre in Huntington Beach, California, and runs Korean corporate health-screening and medical-device distribution businesses. At about KRW 100bn of revenue, Corentec is a sub-scale niche challenger to the global "big four" orthopaedic majors. Its equity story rests on export growth, profitability normalisation after the 2024 trough, and deleveraging. Governance volatility, including four CEO changes since 2023, is the main overhang. --- ### What the company does Corentec designs, manufactures and sells orthopaedic implants and the associated surgical instruments. Joint reconstruction is the core: hip and knee implants account for the large majority of revenue. Product lines (corentec.com product menu; Morningstar; Simply Wall St): - Hip: BENCOX, BENFIX - Knee: LOSPA, EXULT - Shoulder: CORALIS - Spine: LOSPA IS - Sports medicine: CorLock suture anchor - Trauma: LCfit HTO plate, Optirad volar plate Manufacturing is concentrated at the Cheonan plant in South Chungcheong Province. ### Reported business segments | Segment (as reported) | Share of Q2 2026 revenue | Contents | |---|---|---| | Artificial joints (인공관절) | 80% | Corentec parent; hip, knee, shoulder, spine, sports medicine, trauma implants and instruments; Korea and exports including the US | | Medical-device wholesale (의료기기도매) | 16% | Distribution activity, attributed to subsidiary Sun Healthcare International, whose business model includes medical-device distribution (TheVC) | | Information services & ambulatory surgery centre (정보이용 및 외래수술센터) | 4% | Sun Healthcare's B2B health-screening platform and the Sun Surgery Center Huntington ASC in California | Revenue mix by segment, Q2 2026 (Butler, from the H1 2026 report): ### Revenue and business model | Model element | Characterisation | |---|---| | Product vs service | Predominantly product sales of implants (about 80%), plus distribution (about 16%) and services (about 4%: health-screening intermediation, ASC procedures) | | Subscription / licensing | None material disclosed | | Pricing | In Korea, implant pricing is governed by National Health Insurance reimbursement ceilings (structural industry feature; company-specific price lists not disclosed). Export pricing is set with distributors, e.g. contract unit prices under the Biortotec (Mexico) supply agreement (SmartToday, Mar 2023) | | Channel | Domestic: hospital and dealer (대리점) networks. Exports: exclusive or regional distributors (Mexico: Biortotec; India: three regional distributors). US: subsidiary Corentec America (company releases; Medigate 2022) | | Value-chain position | Vertically integrated designer and manufacturer (design, machining, surface treatment, sterilisation and packaging at Cheonan). Downstream exposure through the ASC, the only US ASC owned by a joint-implant maker, per the company in 2022 (Dealsite, Jul 2022) | ### Customers and end-markets **Customers:** orthopaedic surgeons, hospitals (tertiary to secondary), ASCs and national distributors. **End-markets:** primary and revision total hip and knee arthroplasty, shoulder arthroplasty, spinal fusion, sports-medicine soft-tissue repair, and trauma fixation. **Demand driver:** population ageing in Korea and export markets (Korean Investing.com commentary, 2020; company IR, 2018). ### Company self-description vs independent characterisation **Company description.** In its FY2025 results release (10 Feb 2026), the company calls itself Korea's first specialist artificial-joint manufacturer since its founding in 2000. It says it develops hip, knee and spinal-fixation devices, and that FY2025 marked a qualitative change in its earnings structure. **Independent characterisation.** Corentec is a single-plant, export-leveraged orthopaedic implant maker with a defensible Korean hip franchise. The franchise is reported as the domestic hip share leader for seven consecutive years as of 2023 (KED Global, Jul 2023), but the company is No. 3 in Korean knees (Edaily, 2023). Exports run at about 40% of revenue, with the US the largest export market, at roughly KRW 14bn in 2023 (Pharm Edaily, 2024). From 2022 to 2024 management tried to become a "comprehensive healthcare company": - dental prosthetics licensing from RODO Medical; - the Sun Healthcare ASC and screening business; - Woosung Pharmaceutical (generic injectables). The pharmaceutical leg was reversed in March 2025, and the China subsidiary was liquidated in 2024. Since then the company has refocused on the implant core under a profitability and deleveraging agenda.

Revenue$0.1B
Employees172
Market Cap$0.1B
Founded2000
Cheonan, South Korea
Coreana

Coreana Cosmetics Co., Ltd.

Premium
Information Technology

Coreana Cosmetics is a mid-sized, vertically integrated Korean beauty manufacturer founded in 1988. It formulates and produces skincare, colour cosmetics, hair and body products at its own plant and laboratory in Cheonan. It sells them mainly through a door-to-door "beauty counsellor" direct-sales network, which it pioneered at scale in the early 1990s, and supplements this with specialty-store brands, an esthetic salon chain (Cellenique), online channels and exports. A wholly owned subsidiary in Tianjin, China, adds manufacturing and ODM/OEM capacity. Coreana was Korea's third-largest cosmetics company in the 1990s, with revenue above KRW 300 bn at its 2000–2001 peak. It is now a sub-KRW 100 bn niche player: FY2025 revenue was KRW 73.7 bn, with an operating loss of KRW 4.4 bn. The company is debt-light and asset-backed (P/B about 0.6x) but structurally challenged. Its strategic bets are the Ample:N derma brand, online direct sales and global K-beauty distribution. --- **What the company does.** Coreana develops, manufactures and sells cosmetics: basic (skincare), colour, hair and body products. It also runs a skin-care salon chain and earns real-estate rental income. Morningstar classifies the business as household and personal products. Coreana's own product taxonomy groups the range into "solutions" lines: Power Cell, Collagen, Sun, Moisture, Homme, Wrinkle, White, Pore and Clean, plus make-up. The filed objects clause is far broader than current operations. It covers cosmetics and quasi-drug manufacturing, import/export, beauty academies, real-estate leasing, museum operation, health functional foods, e-commerce and skin-care devices. The company actively uses only a fraction of these. **Company's own description (paraphrased from filings and corporate profile).** Management describes Coreana as a company that has pursued "Only the Best" quality for over three decades under the slogan "Art through Nature". Its stated management principles are customer satisfaction, ethical (정도) management and a "luxury-goods" (명품주의) product philosophy. Its own facilities handle research, production and distribution. The FY2025 business report ascribes the year's losses to three factors: - input-cost inflation that has become structurally embedded; - a prolonged slowdown in Greater China, together with weaker K-beauty competitiveness, which stalled exports; - a contracting person-to-person (방문판매) sales market. **Revenue model.** Revenue is almost entirely product sales, with small service and rental components: **Product mix (latest).** In Q2 2026, basic (skincare) cosmetics made up about 72% of revenue, "other cosmetics" (hair, body, other) about 22%, colour cosmetics about 5% and other sales about 1% (DART business segment data via Butler). **Value-chain position.** Coreana is an integrated brand owner. It controls formulation (Song-pa Institute of Technology), manufacturing (Cheonan plants 1 and 2; Tianjin plant), brand marketing and a large part of distribution (direct sales, own salons, own online malls). This contrasts with asset-light "indie" K-beauty brands, which outsource production to ODMs such as Cosmax, Kolmar Korea or Cosmecca. Coreana also acts as an ODM/OEM supplier in China through its Tianjin subsidiary. **Customer types and end-markets.** The core domestic customer is a middle-aged and older Korean woman, reached through relationship-based direct selling. That demographic is ageing, and its channel is shrinking. Ample:N, with K-pop brand ambassadors The Boyz's Hyunjae (2023–24) and Seventeen's Dokyeom (2025–26), targets 20–30-year-olds through Olive Young and Chicor. B2B customers include Chinese brand owners and distributors served from Tianjin, plus overseas distributors (Thailand Watsons, Philippines Shopee, Tmall Global flagship). **Independent characterisation.** Coreana is a legacy direct-sales cosmetics house whose franchise has eroded for two decades. Revenue fell from roughly KRW 300–400 bn (2000–2003) to KRW 73.7 bn (FY2025). The company has kept its manufacturing and R&D base intact rather than becoming asset-light. That base, a debt-free balance sheet and a large treasury-share holding explain why the stock trades at about 0.6x book. The operating question is whether younger brands (Ample:N) and export or online channels can grow faster than the legacy direct-sales franchise declines. Through H1 2026, they have not.

Revenue$0.1B
Employees167
Market CapN/A
Founded1988
Cheonan, South Korea
COOCON

COOCON Corporation

Premium
Information Technology

COOCON is South Korea's leading independent business-data and payment-connectivity infrastructure provider. It sits between data holders — roughly 500 domestic financial, public, medical, logistics and telecom institutions, plus around 2,000 institutions across about 40 countries — and the banks, card companies, insurers, brokerages, big-tech platforms and fintechs that need that data or payment rails inside their own products. COOCON standardises more than 50,000 data types into 300-plus APIs sold through COOCON.net, and operates payment plumbing (firm-banking, e-finance, easy-payment linkage, ATM withdrawal via roughly 40,000 machines, and QR acceptance across more than 2 million merchants). Revenue is predominantly transaction- and call-based fees, generating structurally high operating margins (27.2% in FY2025). Management is repositioning the company from a domestic API utility into an AI-ready data platform (MCP products) and a cross-border payment hub spanning inbound tourist payments and stablecoin settlement. --- ### What the company does COOCON collects, normalises and connects data and payment functions that are fragmented across hundreds of institutions, and resells them to enterprise customers as standardised application programming interfaces (APIs). Its CEO's own description at IPO was that non-face-to-face account opening or loan origination requires prior information — personal income, identity verification, asset information, bank transaction history — and COOCON's role is to collect, process and deliver that evidentiary data so that individuals and businesses can transact conveniently (CEO interview, Money Today, April 2021). Aggregator profiles drawn from company disclosures describe COOCON as a business data platform that collects, connects and organises information; operates COOCON.net; and offers personal-information APIs, corporate-information APIs, electronic-financial APIs, easy-payment APIs and global APIs, plus services to build and operate computing infrastructure. Its global APIs cover overseas bank-account inquiry, cash management and e-commerce purchase/payment data for firms with international operations. ### Business model and revenue model | Dimension | Characterisation | |---|---| | Core model | B2B data and payment infrastructure ("API-as-a-service"); no consumer-facing business of scale | | Revenue type | Predominantly usage-based fees (per API call, per transaction, per settlement) — management repeatedly describes the shift toward "fee revenue" (수수료 매출) and away from "large one-off projects" | | Secondary revenue | Project/implementation revenue (e.g., MyData platform builds such as the Credit Counseling & Recovery Service deployment in 2026; large financial-institution projects such as the Saemaul Geumgo-related project in 2023 and the Q2 2024 one-off project) | | Licensing/subscription | Not separately disclosed; certain solutions (MyData All-in-One) are sold as packaged solutions, pricing undisclosed | | Product vs. service mix | Effectively 100% services; no hardware | | Operating leverage | High: incremental API calls on existing connections carry low marginal cost, which is why segment margins rose in 2025 even as revenue fell | ### Value-chain position COOCON occupies the middleware layer: upstream are data sources (banks, card issuers, insurers, government portals, the Supreme Court registry, health insurers, telecoms) and payment networks (bank firm-banking, ATM operators, QR merchant networks, foreign wallets); downstream are application-layer customers (Toss, Kakao Pay, Naver, Upbit, Bithumb, card companies, banks, PG companies, delivery platforms, insurers, local-currency operators). The company explicitly markets itself as "COOCON inside" — invisible infrastructure embedded in customer apps (Money Today, April 2021: "the Intel of fintech"). ### Customer types and end-markets | Customer type | Examples disclosed | Typical use | |---|---|---| | Big tech / fintech | Toss, Kakao Pay, Naver, Toss Place (terminal) | Firm-banking, authentication, account linking, data aggregation | | Crypto exchanges | Upbit, Bithumb | Firm-banking and authentication APIs | | Banks | IBK (also a shareholder), major banks (unnamed) | Electronic certificates, public-data platform, face-to-face MyData | | Card companies | KB Kookmin Card (KB Pay minor onboarding) | Non-face-to-face onboarding, compliance | | Securities firms | Hanwha Investment & Securities | Supreme Court certificate API for minors' account opening | | Insurers | Hyundai Marine & Fire (We-Check for foreign subscribers) | Document submission automation, vehicle data | | PG / payment companies | "Large PG companies" (unnamed) | Firm-banking, pre-settlement | | Public sector | Seoul Metropolitan Government (Seoul Pay global settlement operator), Credit Counseling & Recovery Service | Global QR settlement, MyData counselling | | Local-currency operators | Kona I, KT | Local currency linkage services | | Automakers / mobility | Unnamed automakers | Vehicle data APIs | | Healthcare | K-Bio Healthcare | Medical data APIs (treatment, check-ups, medication) | The company reported more than 1,900 enterprise customers across finance, medical, distribution and logistics at the time of its 2023 data-specialised-institution designation, and Hana Securities (June 2026) cited more than 200 domestic financial-institution customers. ### Independent characterisation COOCON is best understood as a toll-road operator on Korean digital finance. Its moat is less proprietary technology than accumulated connectivity, licences and operational reliability: it holds an electronic financial business licence, a MyData (personal credit information management) licence, foreign-exchange business registration and data-specialised-institution designation — a combination that few independent companies of its size hold. The trade-off is cyclicality in the underlying transaction volumes (loan comparison, crypto trading, PG firm-banking) and exposure to regulatory change: standardised MyData APIs can commoditise scraping, while lending curbs directly hit loan-inquiry volumes. The company's 2025–26 strategy is an attempt to escape the domestic-volume ceiling through cross-border payments, stablecoin rails and AI-agent data distribution.

Revenue$0.0B
Employees204
Market CapN/A
Founded2006
Seoul, South Korea
ContentreeJoongAng

ContentreeJoongAng corp.

Premium
Information Technology

ContentreeJoongAng is the listed intermediate holding company of South Korea's JoongAng Group content businesses. It sits between the group's media holding structure (JoongAng Holdings and JoongAng P&I) and two operating platforms. The first is SLL JoongAng, one of Korea's two largest scripted-content studios, which owns a network of label studios, the US producer wiip, the unscripted producer Studio Slam, and a K-pop label. The second is Megabox JoongAng, Korea's third-largest multiplex chain by screens, which also houses the film investor-distributor Plus M Entertainment. Over 2021–2025 the company tried to become a global IP studio funded by leverage and pre-IPO capital. Production economics improved in 2025, when SLL posted record revenue and its first annual operating profit since 2021. However, recurring theatre losses, upstream support for affiliates, short-dated high-cost funding, and the June 2026 JTBC default pushed the company into court rehabilitation. Its equity value now depends on the outcome of a rehabilitation plan due 15 December 2026 and on the fate of SLL and Megabox in asset sales. --- ### What the company does ContentreeJoongAng is a holding company. Almost all of its consolidated revenue comes from two subsidiaries: 1. **Content (SLL JoongAng and its labels).** SLL plans, finances, produces and distributes Korean dramas (for the captive JTBC channel, Korean OTT platforms such as TVING, and global OTTs including Netflix, Prime Video and Disney+), feature films, unscripted entertainment, and music. Its US subsidiary wiip produces English-language premium series for US platforms. SLL also owns about 12.7–12.8% of the OTT platform TVING. 2. **Space / exhibition (Megabox JoongAng).** Megabox operates the Megabox multiplex brand: 114 sites at Q1 2026, of which 42 are directly operated and 72 are consignment/franchise. Its Plus M Entertainment division invests in and distributes Korean films, and Playtime JoongAng runs indoor children's play facilities in Korea and abroad (Vietnam, Mongolia). Third-party profiles of the company also list a magazine/consumer-trend business ("HLL") and IT and media-operation services for group affiliates. Their scale is not separately disclosed in accessible sources and appears immaterial to consolidated revenue. ### Business and revenue model | Revenue stream | Model | Primary entity | |---|---|---| | Drama production fees and broadcast licensing (captive JTBC slots) | Project-based; production fee plus licence; profitability linked to the "recoup rate" (share of production cost recovered via pre-sales) | SLL (separate) | | Global/domestic OTT licensing (simultaneous streaming, regional rights, OTT originals) | Licensing (pre-sale) and commissioned originals | SLL, labels | | Library / secondary rights | Licensing of catalogue IP (company reports ~279 JTBC IP titles transferred to SLL, per secondary analysis) | SLL | | US premium episodic production | Cost-plus/commission deliveries to US streamers (episodes recognised on delivery) | wiip | | Unscripted production | Commissioned formats (e.g., *Culinary Class Wars* S2, *Sing Again*) | Studio Slam (consolidated from Q2 2025) | | Music / artist management | Album sales, concerts, IP (e.g., boy group CLOSE YOUR EYES) | Uncore (SLL label) | | Short-form drama | Commissioned vertical drama for global short-drama apps (e.g., GoodShort) | SLL | | Cinema admissions | Ticket revenue; average ticket price (ATP) lifted by premium formats | Megabox | | Concessions and merchandise | Per-capita spending (CPP); fandom goods | Megabox | | Screen advertising | Advertising | Megabox | | Film investment and distribution | Equity in film slates plus distribution fees | Plus M Entertainment | | Indoor play parks | Admissions/F&B | Playtime JoongAng | **Product vs. service vs. licensing mix.** The company does not report revenue by product, service, subscription and licensing. Our characterisation: in FY2025 roughly 60%+ of consolidated revenue was content (production fees plus licensing, project-based) and roughly 25% was exhibition (a consumer service). The remainder was distribution, play parks and other. This is derived from SLL consolidated revenue of KRW 670.4B and Megabox revenue of KRW 267.5B against consolidated revenue of KRW 1,083.3B. Intersegment eliminations are not disclosed. ### Value-chain position The group is vertically integrated across IP development → production → financing → distribution (film) → exhibition (cinema). Through JTBC (a sister company, not a subsidiary) it also has a captive linear channel. The captive-channel relationship is an advantage, because it guarantees time slots. It is also a liability: JTBC's advertising decline and default in 2026 directly undermined the group. ### Customer types and end-markets **B2B platform customers:** JTBC (captive), Netflix, Prime Video, Disney+, Coupang Play, TVING, U-NEXT (Japan), Viu (SE Asia), HBO/Max (via wiip), TV Asahi (co-production). **B2C consumers:** cinema-goers (Megabox), families (Playtime), music fans (Uncore artists). **End-markets:** Korean scripted TV and OTT content; global streaming content; Korean theatrical exhibition; Korean film distribution; kids' leisure. ### Company's own description vs. independent view Company materials and third-party summaries describe ContentreeJoongAng as a comprehensive media-content company. In recent years, they say, it has reshaped its portfolio away from space/exhibition toward content production and IP investment, expanding OTT-oriented production for domestic and global platforms. **Independent characterisation.** ContentreeJoongAng is in practice a financially distressed holding company. It owns one structurally improving but over-levered studio (SLL), one structurally challenged exhibitor (Megabox), and a web of intra-group credit support. By early 2026 its operating recovery (FY2025 consolidated operating profit of KRW 8.8B) was too small relative to its capital structure to service it: FY2025 total liabilities of KRW 1,894.7B against equity of KRW 596.2B, and cash down to KRW 77.4B at Q1 2026. When group refinancing access closed in June 2026, the company could not avoid rehabilitation.

Revenue$0.8B
Employees136
Market Cap$0.0B
Founded1987
Seoul, South Korea

Page 78 of 482

1…777879…482

Page 78 of 482

Go to page
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo